Introduction {#s1}
============

Cells of photosynthesizing eukaryotes are unique in harboring two types of energy organelles, the chloroplasts and the mitochondria, which interact at an operational level by the exchange of metabolites, energy and reducing power ([@bib86]; [@bib13]; [@bib7]). Reducing power flows between the organelles through several pathways, including photorespiration ([@bib119]), malate shuttles ([@bib97]; [@bib128]) and transport of photoassimilate-derived carbon rich metabolites from chloroplasts to mitochondria. At the signaling level, the so-called retrograde signaling pathways originating from the organelles influence the expression of nuclear genes ([@bib25]; [@bib69]; [@bib118]). These pathways provide feedback communication between the organelles and the gene expression apparatus in the nucleus to adjust expression of genes encoding organelle components in accordance with changes in the developmental stage or environmental conditions.

Reactive oxygen species (ROS), inevitable by-products of aerobic energy metabolism, play pivotal roles in plant organellar signaling from both chloroplasts and mitochondria ([@bib26]; [@bib85]; [@bib118]). Superoxide anion radical (O~2~**˙ ^--^**) is formed in the organelles by the transfer of electrons from the organellar electron transfer chains (ETCs) to molecular oxygen (O~2~). In illuminated chloroplasts, superoxide anion formed from O~2~ reduction by Photosystem I (PSI) is converted to hydrogen peroxide (H~2~O~2~) which is further reduced to water by chloroplastic H~2~O~2~-scavenging systems during the water-water cycle ([@bib5]; [@bib6]). Chloroplastic ROS production can be enhanced by application of methyl viologen (MV), a chemical that catalyzes shuttling of electrons from PSI to O~2~ ([@bib29]). The immediate product of this reaction, O~2~**˙ ^--^**, is not likely to directly mediate organellar signaling; however, H~2~O~2~ is involved in many retrograde signaling pathways ([@bib69]; [@bib77]; [@bib118]). Organellar H~2~O~2~ has been suggested to translocate directly to the nucleus ([@bib12]; [@bib28]), where it can oxidize thiol groups of specific proteins, thereby converting the ROS signal into thiol redox signals ([@bib75]; [@bib82]). One recently discovered process affected by chloroplastic H~2~O~2~ is the metabolism of 3\'-phosphoadenosine 5\'-phosphate (PAP). PAP is a toxic by-product of sulfate metabolism produced when cytoplasmic sulfotransferases (SOTs, e.g., SOT12) transfer a sulfuryl group from PAP-sulfate (PAPS) to various target compounds ([@bib58]). PAP is transported to chloroplasts where it is detoxiﬁed by dephosphorylation to adenosine monophosphate in a reaction catalyzed by the adenosine bisphosphate phosphatase 1, SAL1 ([@bib95]; [@bib16]). It has been proposed that oxidation of SAL1 thiols directly or indirectly dependent on chloroplastic H~2~O~2~ inactivates the enzyme, and accumulating PAP may act as a retrograde signal ([@bib27]; [@bib16]; [@bib18]).

ROS are also produced in the mitochondria, for example by complex III at the outer side of the inner mitochondrial membrane ([@bib21]; [@bib81]; [@bib46]; [@bib117]). Blocking electron transfer through complex III by application of the inhibitors antimycin A (AA) or myxothiazol (myx) enhances electron leakage and thus induces the retrograde signal. Two known mediators of this signal are the transcription factors ANAC013 ([@bib23]) and ANAC017 ([@bib80]; [@bib113]) that are both bound to the endoplasmic reticulum (ER) by a transmembrane domain. Mitochondria-derived signals lead to proteolytic cleavage of this domain. The proteins are released from the ER and translocated to the nucleus where they activate the mitochondrial dysfunction stimulon (MDS) genes ([@bib23]; [@bib112]). MDS genes include the mitochondrial alternative oxidases (*AOXs*), *SOT12*, and *ANAC013* itself, which provides positive feedback regulation and thus enhancement of the signal.

Whereas multiple retrograde signaling pathways have been described in detail ([@bib25]; [@bib69]; [@bib118]), it is still largely unknown how the numerous chloroplast- and mitochondria-derived signals are integrated and processed by the nuclear gene expression system. Nuclear cyclin-dependent kinase E is implicated in the expression of both chloroplastic (*LHCB2.4*) and mitochondrial (*AOX1a*) components in response to perturbations of chloroplast ETC ([@bib9]), mitochondrial ETC, or H~2~O~2~ treatment ([@bib79]). The transcription factor ABI4 is also suggested to respond to retrograde signals from both organelles ([@bib39]; [@bib9]), although its significance in chloroplast signaling has recently been disputed ([@bib54]). Mitochondrial signaling *via* ANAC017 was recently suggested to converge with chloroplast PAP signaling based on similarities in their transcriptomic profiles ([@bib114]). However, the mechanistic details underlying this convergence remain currently unknown.

Arabidopsis RADICAL-INDUCED CELL DEATH1 (RCD1) is a nuclear protein containing a WWE, a PARP-like \[poly (ADP-ribose) polymerase-like\], and a C-terminal RST domain ([R]{.ul}CD1-[S]{.ul}RO1-[T]{.ul}AF4) ([@bib90]; [@bib1]; [@bib50]; [@bib51]). In yeast two-hybrid studies RCD1 interacted with several transcription factors ([@bib50]) including ANAC013, DREB2A ([@bib109]), and Rap2.4a ([@bib45]) *via* the RST domain ([@bib52]), and with the sodium transporter SOS1 ([@bib55]). In agreement with the numerous potential interaction partners of RCD1, the *rcd1* mutant demonstrates pleiotropic phenotypes in diverse stress and developmental responses ([@bib50]). It has been identified in screens for sensitivity to ozone ([@bib90]), tolerance to MV ([@bib33]) and redox imbalance in the chloroplasts ([@bib43]; [@bib45]). RCD1 was found to complement the deficiency of the redox sensor YAP1 in yeast ([@bib8]). Under standard growth conditions, the *rcd1* mutant displays differential expression of over 400 genes, including those encoding mitochondrial AOXs ([@bib50]; [@bib10]) and the chloroplast 2-Cys peroxiredoxin (2-CP) ([@bib43]; [@bib45]).

Here we have addressed the role of RCD1 in the integration of ROS signals emitted by both mitochondria and chloroplasts. Abundance, redox status and oligomerization state of the nuclear-localized RCD1 protein changed in response to ROS generated in the chloroplasts. Furthermore, RCD1 directly interacted in vivo with ANAC013 and ANAC017 and appeared to function as a negative regulator of both transcription factors. The RST domain, mediating RCD1 interaction with ANAC transcription factors, was required for plant sensitivity to chloroplastic ROS. We demonstrate that RCD1 is a molecular component that integrates organellar signal input from both chloroplasts and mitochondria to exert its influence on nuclear gene expression.

Results {#s2}
=======

The response to chloroplastic ROS is compromised in *rcd1* {#s2-1}
----------------------------------------------------------

Methyl viologen (MV) enhances ROS generation in illuminated chloroplasts by catalyzing the transfer of electrons from Photosystem I (PSI) to molecular oxygen. This triggers a chain of reactions that ultimately inhibit Photosystem II (PSII) ([@bib29]; [@bib84]). To reveal the significance of nuclear protein RCD1 in these reactions, rosettes of Arabidopsis were pre-treated with MV in darkness. Without exposure to light, the plants displayed unchanged PSII photochemical yield (Fv/Fm). Illumination resulted in a decrease of Fv/Fm in wild type (Col-0), but not in the *rcd1* mutant ([Figure 1A](#fig1){ref-type="fig"}), suggesting increased tolerance of *rcd1* to chloroplastic ROS production. Analysis of several independent *rcd1* complementation lines expressing different levels of HA-tagged RCD1 revealed that tolerance to MV inversely correlated with the amount of expressed RCD1 ([Figure 1---figure supplements 1](#fig1s1){ref-type="fig"} and [2](#fig1s2){ref-type="fig"}). This suggests that RCD1 protein quantitatively lowered the resistance of the photosynthetic apparatus to ROS.

![RCD1 controls tolerance of photosynthetic apparatus to ROS.\
(**A**) MV treatment results in PSII inhibition under light, which is suppressed in the *rcd1* mutant. PSII photochemical yield (Fv/Fm) was measured in rosettes pre-treated overnight in darkness with 1 μM MV and then exposed to 3 hr of continuous light (80 µmol m^−2^ s^−1^). Representative false-color image of Fv/Fm is shown. (**B**) Access of MV to electron-acceptor side of PSI is unaltered in *rcd1*. Treatment with MV led to similar changes in kinetics of PSI oxidation in Col-0 and *rcd1*. Oxidation of PSI reaction center (P700) was measured using DUAL-PAM. Leaves were first adapted to far-red light that is more efficiently used by PSI than PSII. In these conditions PSI is producing electrons at a faster rate than they are supplied by PSII, thus P700 is oxidized. Then a flash of orange light was provided that is efficiently absorbed by PSII (orange arrow). Electrons generated by PSII transiently reduced PSI, after which the kinetics of PSI re-oxidation was followed. Note the progressive decrease in the effect of the orange flash occurring in Col-0 at later time points, which suggests deterioration in PSII function. This was not observed in *rcd1*. Three leaves from three individual plants were used for each measurement. The experiment was repeated three times with similar results. (**C**) Redox state of the chloroplast enzyme 2-Cys peroxiredoxin (2-CP) assessed by thiol bond-specific labeling in Col-0 (left) and *rcd1* (right). Total protein was isolated from leaves incubated in darkness (**D**), or under light (**L**). Free sulfhydryls were blocked with N-ethylmaleimide, then in vivo thiol bridges were reduced with DTT, and finally the newly exposed sulfhydryls were labeled with methoxypolyethylene glycol maleimide of molecular weight 5 kDa. The labeled protein extracts were separated by SDS-PAGE and immunoblotted with α2-CP antibody. DTT (-) control contained predominantly unlabeled form. Unlabeled reduced (red), singly and doubly labeled oxidized forms and the putative dimer were annotated as in [@bib83]. Apparent molecular weight increment after the labeling of one thiol bond appears on SDS-PAGE higher than 10 kDa because of steric hindrance exerted on branched polymers during gel separation ([@bib115]). The experiment was repeated three times with similar results.\
10.7554/eLife.43284.009Figure 1---source data 1.Source data and statistics.](elife-43284-fig1){#fig1}

Treatment with MV leads to formation of superoxide that is enzymatically dismutated to the more long-lived H~2~O~2~. Chloroplastic production of H~2~O~2~ in the presence of MV was assessed by staining plants with 3,3′-diaminobenzidine (DAB) in light. Higher production rate of H~2~O~2~ was evident in MV pre-treated rosettes of both Col-0 and *rcd1*. Longer illumination led to a time-dependent increase in the DAB staining intensity in Col-0, but not in *rcd1* ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In several MV-tolerant mutants, the resistance is based on restricted access of MV to chloroplasts ([@bib42]). However, in *rcd1* MV pre-treatment led to an initial increase in H~2~O~2~ production rate similar to that in the wild type ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}), suggesting that resistance of *rcd1* was not due to lowered delivery of MV to PSI. To test this directly, the kinetics of PSI oxidation was assessed by in vivo spectroscopy using DUAL-PAM. As expected, pre-treatment of leaves with MV led to accelerated oxidation of PSI. This effect was identical in Col-0 and *rcd1*, indicating unrestricted access of MV to PSI in the *rcd1* mutant ([Figure 1B](#fig1){ref-type="fig"}).

The MV toxicity was not associated with the changed stoichiometry of photosystems ([Figure 1---figure supplement 4A](#fig1s4){ref-type="fig"}). However, in Col-0 it coincided with progressive destabilization of PSII complex with its light-harvesting antennae (LHCII) and accumulation of PSII monomer ([Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}). No signs of PSI inhibition were evident either in DUAL-PAM ([Figure 1B](#fig1){ref-type="fig"}) or in PSI immunoblotting assays ([Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}) in either genotype. The fact that production of ROS affected PSII, but not PSI where these ROS are formed, suggests that PSII inhibition results from a regulated mechanism rather than uncontrolled oxidation by ROS, and that this mechanism requires the activity of RCD1.

Previous studies have described *rcd1* as a mutant with altered ROS metabolism and redox status of the chloroplasts, although the underlying mechanisms are unknown ([@bib33]; [@bib43]; [@bib45]; [@bib20]). No significant changes were detected in *rcd1* in transcript levels of chloroplast-related genes ([@bib10]). Analyses of the low molecular weight antioxidant compounds ascorbate and glutathione did not explain the tolerance of *rcd1* to chloroplastic ROS either ([@bib43]; [@bib45]). To understand the molecular basis of the RCD1-dependent redox alterations, the levels of chloroplast proteins related to photosynthesis and ROS scavenging were analyzed by immunoblotting. None of these showed significantly altered abundance in *rcd1* compared to Col-0 ([Figure 1---figure supplement 5A](#fig1s5){ref-type="fig"}). Furthermore, no difference was detected between the genotypes in abundance and subcellular distribution of the nucleotide redox couples NAD^+^/NADH and NADP^+^/NADPH ([Figure 1---figure supplement 5B,C](#fig1s5){ref-type="fig"}). Finally, the redox status of chloroplast thiol redox enzymes was addressed. The chloroplast stroma-localized 2-Cys peroxiredoxin (2-CP) is an abundant enzyme ([@bib61]; [@bib92]; [@bib71]) that was recently found to link chloroplast thiol redox system to ROS ([@bib89]; [@bib116]; [@bib127]). The level of the 2-CP protein was unchanged in *rcd1* ([Figure 1---figure supplement 5A](#fig1s5){ref-type="fig"}). However, when protein extracts were subjected to thiol bond-specific labeling ([@bib83]) as described in [Figure 1C](#fig1){ref-type="fig"}, most 2-CP was reduced in *rcd1* both in darkness and in light, while in Col-0 the larger fraction of 2-CP was present as oxidized forms. Thus, RCD1 is likely involved in the regulation of the redox status of chloroplastic thiol enzymes.

Taken together, the results hinted that the mechanisms by which RCD1 regulates chloroplastic redox status are independent of the photosynthetic ETC, or steady-state levels and distribution of nucleotide electron carriers. However, they appear to be associated with changed thiol redox state of chloroplast enzymes.

RCD1 protein is sensitive to ROS {#s2-2}
--------------------------------

It was next tested whether the nuclear RCD1 protein could itself be sensitive to ROS, thus accounting for the observed alterations. For that, an RCD1-HA complementation line was used (line '*a*' in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). No changes were detected in RCD1-HA abundance during 5 hr amid the standard growth light period, or during 5 hr high light treatment. On the other hand, both MV and H~2~O~2~ treatments led to a gradual decrease in RCD1 abundance ([Figure 2A](#fig2){ref-type="fig"}). When plant extracts from these experiments were separated in non-reducing SDS-PAGE, the RCD1-HA signal resolved into species of different molecular weights ([Figure 2B](#fig2){ref-type="fig"}). Under standard growth conditions or high light, most RCD1-HA formed a reduced monomer. In contrast, treatment with MV under light or H~2~O~2~ resulted in fast conversion of RCD1-HA monomers into high-molecular-weight aggregates ([Figure 2B](#fig2){ref-type="fig"}). Importantly, MV-induced redox changes in RCD1-HA only occurred in light, but not in darkness, suggesting that the changes were mediated by increased chloroplastic ROS production ([Figure 2B](#fig2){ref-type="fig"} and [Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}). To test whether oligomerization of RCD1 was thiol-regulated, a variant of RCD1-HA was generated where seven cysteines in the linkers between the RCD1 domains were substituted by alanines (RCD1Δ7Cys; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The treatments of *rcd1*: RCD1Δ7Cys-HA plants with MV or H~2~O~2~ led to significantly less aggregation of RCD1Δ7Cys-HA compared to RCD1-HA. In addition, the levels of RCD1Δ7Cys-HA were insensitive to MV or H~2~O~2~ ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). In three independent complementation lines the RCD1Δ7Cys-HA variant accumulated to higher levels compared to RCD1-HA ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). This suggests the involvement of the tested RCD1 cysteine residues in the regulation of the protein oligomerization and stability in vivo. However, the tolerance of the RCD1Δ7Cys-HA lines to chloroplastic ROS and the expression of the selected RCD1-regulated genes in response to MV treatment were comparable to that of the RCD1-HA lines or Col-0 ([Figure 2---figure supplement 1C,D](#fig2s1){ref-type="fig"}). These results suggest that the RCD1 protein is sensitive to chloroplastic ROS. However, the changes in RCD1 abundance and redox state did not explain the RCD1-dependent redox alterations observed in the chloroplasts.

![RCD1 protein is sensitive to chloroplastic ROS.\
(**A**) The *rcd1*: RCD1-HA complementation line was used to assess RCD1-HA abundance. It gradually decreased in response to chloroplastic ROS. Leaf discs from plants expressing HA-tagged RCD1 were treated with 5 hr growth light (150 µmol m^−2^ s^−1^), high light (1300 µmol m^−2^ s^−1^), MV (1 µM) in light, or H~2~O~2~ (100 mM). The levels of RCD1-HA were monitored by immunoblotting with αHA at indicated time points. Rubisco large subunit (RbcL) detected by amido black staining is shown as a control for equal protein loading. The '0' time point of the MV time course represents dark-adapted leaf discs pre-treated with MV overnight. The experiment was performed four times with similar results. (**B**) Chloroplastic ROS caused oligomerization of RCD1-HA. Total protein extracts from the plants treated as in panel (**A**) were separated by non-reducing PAGE and immunoblotted with αHA antibody. Reduced (red) and oxidized (ox) forms of the protein are labeled. To ascertain that all HA-tagged protein including that forming high-molecular-weight aggregates has been detected by immunoblotting, the transfer to a membrane was performed using the entire SDS-PAGE gel including the stacking gel and the well pockets. The experiment was performed four times with similar results.\
10.7554/eLife.43284.012Figure 2---source data 1.Source data and statistics.](elife-43284-fig2){#fig2}

Mitochondrial respiration is altered in *rcd1* {#s2-3}
----------------------------------------------

In further search for the mechanisms of RCD1-dependent redox alterations in the chloroplast ([Figure 1](#fig1){ref-type="fig"}), analysis of cell energy metabolism was performed by feeding uniformly labeled \[U-^14^C\] glucose to leaf discs from light- and dark-adapted Col-0 and *rcd1* plants. Distribution of radioactive label between emitted ^14^CO~2~ and fractionated plant material was analyzed. This revealed significantly more active carbohydrate metabolism in *rcd1* ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). The redistribution of radiolabel to sucrose, starch and cell wall was elevated in *rcd1* as were the corresponding deduced fluxes ([Figure 3](#fig3){ref-type="fig"}), suggesting that *rcd1* displayed a higher respiration rate indicative of mitochondrial defects.

![Altered energy metabolism of *rcd1*.\
Deduced metabolic fluxes in light- and dark- adapted Col-0 and *rcd1* rosettes were assessed by fractionation of the extracts of leaves treated with \[U-^14^C\] glucose. Increased respiration flux and higher amount of total metabolized glucose ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}) in *rcd1* suggest a more active glycolytic pathway. Higher cell wall metabolic flux in *rcd1* provided indirect support of increased operation of the oxidative pentose phosphate pathway which is required for generating pentoses used in cell wall biosynthesis ([@bib3]). Mean ±SE are presented. Asterisks indicate values significantly different from the wild type, \*\*P value \< 0.01, \*P value \< 0.05, Student's t-test. Source data and statistics are presented in [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}.\
10.7554/eLife.43284.014Figure 3---source data 1.Metabolic analyses.Distribution of radioactive label was analyzed after feeding plants with ^14^C-labeled glucose. Metabolic fluxes in light- and dark-adapted Col-0, *rcd1*, *rcd1 aox1a*, and *aox1a* plants were deduced.\
10.7554/eLife.43284.015Figure 3---source data 2.Source data and statistics.](elife-43284-fig3){#fig3}

Indeed, earlier transcriptomic studies in *rcd1* have revealed increased expression of genes encoding mitochondrial functions, including mitochondrial alternative oxidases (*AOXs*) ([@bib50]; [@bib10]). Immunoblotting of protein extracts from isolated mitochondria with an antibody recognizing all five isoforms of Arabidopsis AOX confirmed the increased abundance of AOX in *rcd1* ([Figure 4A](#fig4){ref-type="fig"}). The most abundant AOX isoform in Arabidopsis is AOX1a. Accordingly, only a weak signal was detected in the *aox1a* mutant. However, in the *rcd1 aox1a* double mutant AOXs other than AOX1a were evident, thus the absence of RCD1 led to an increased abundance of several AOX isoforms.

![Mitochondrial AOXs affect energy metabolism of *rcd1* and alter response to chloroplastic ROS.\
Source data and statistics are presented in [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}. (**A**) Expression of AOXs is induced in *rcd1.* Abundance of AOX isoforms in mitochondrial preparations was assessed by immunoblotting with αAOX antibody that recognizes AOX1a, -b, -c, -d, and AOX2 isoforms. 100% corresponds to 15 μg of mitochondrial protein. (**B**) Two mitochondrial respiratory pathways (red arrows) and sites of action of mitochondrial inhibitors. KCN inhibits complex IV (cytochrome c oxidase). Salicylhydroxamic acid (SHAM) inhibits AOX activity. Antimycin A (AA) and myxothiazol (myx) block electron transfer through complex III (ubiquinol-cytochrome c oxidoreductase), creating ROS-related mitochondrial retrograde signal. (**C**) AOX capacity is significantly increased in *rcd1*. Oxygen uptake by seedlings was measured in the darkness in presence of KCN and SHAM. Addition of KCN blocked respiration through complex IV, thus revealing the capacity of the alternative respiratory pathway through AOXs. Data are presented as mean ±SD, asterisks denote selected values that are significantly different (P value \< 0.001, one-way ANOVA with Bonferroni post hoc correction). Each measurement was performed on 10--15 pooled seedlings and repeated at least three times. (**D**) Inhibitors of mitochondrial complex III increase plant tolerance to chloroplastic ROS. Effect of pre-treatment with 2.5 μM AA or 2.5 μM myx on PSII inhibition (Fv/Fm) by MV. For each experiment, leaf discs from at least four individual rosettes were used. The experiment was performed four times with similar results. Mean ±SD are shown. Asterisks indicate selected treatments that are significantly different (P value \< 0.001, Bonferroni post hoc correction). AOX abundance in the leaf discs treated in the same way was quantified by immunoblotting ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). (**E**) AOX inhibitor SHAM decreases plant tolerance to chloroplastic ROS. 1 hr pre-treatment with 2 mM SHAM inhibited tolerance to 1 μM MV both in Col-0 and *rcd1* as measured by Fv/Fm. SHAM stock solution was prepared in DMSO, thus pure DMSO was added in the SHAM-minus controls. For each experiment, leaf discs from at least four individual rosettes were used. The experiment was performed four times with similar results. Mean ±SD are shown. Asterisks indicate significant difference in the treatments of the same genotype at the selected time points (P value \< 0.001, Bonferroni post hoc correction).\
10.7554/eLife.43284.021Figure 4---source data 1.Source data and statistics.](elife-43284-fig4){#fig4}

To test whether the high abundance of AOXs in *rcd1* correlated with their increased activity, seedling respiration was assayed in vivo. Mitochondrial AOXs form an alternative respiratory pathway to the KCN-sensitive electron transfer through complex III and cytochrome c ([Figure 4B](#fig4){ref-type="fig"}). Thus, after recording the initial rate of O~2~ uptake, KCN was added to inhibit cytochrome-dependent respiration. In Col-0 seedlings KCN led to approximately 80% decrease in O~2~ uptake, *versus* only about 20% in *rcd1*, revealing elevated AOX capacity of the mutant ([Figure 4C](#fig4){ref-type="fig"}). The elevated AOX capacity of *rcd1* was similar to that of an *AOX1a*-OE overexpressor line ([@bib108]). In the *rcd1 aox1a* double mutant the AOX capacity was comparable to Col-0 or *aox1a* ([Figure 4C](#fig4){ref-type="fig"}). Thus, elevated AOX respiration of *rcd1* seedlings was dependent on the AOX1a isoform. Importantly, however, metabolism of *rcd1 aox1a* was only slightly different from *rcd1* under light and indistinguishable from *rcd1* in the darkness ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). This again indicated that the studied phenotypes of *rcd1* are associated with the induction of more than one AOX isoform. Taken together, the results suggested that inactivation of *RCD1* led to increased expression and activity of AOX isoforms, which could contribute to the observed changes in energy metabolism of *rcd1* ([Figure 3](#fig3){ref-type="fig"}).

Mitochondrial AOXs affect ROS processing in the chloroplasts {#s2-4}
------------------------------------------------------------

Inhibition of complex III by antimycin A (AA) or myxothiazol (myx) activates mitochondrial retrograde signaling ([Figure 4B](#fig4){ref-type="fig"}). It leads to nuclear transcriptional reprogramming including induction of *AOX* genes ([@bib17]). Accordingly, overnight treatment with either of these chemicals significantly increased the abundance of AOXs in Col-0, *rcd1* and *rcd1 aox1a* ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Thus, sensitivity of *rcd1* to the complex III retrograde signal was not compromised, rather continuously augmented. In addition, no major effect was observed on RCD1-HA protein level or redox state in the RCD1-HA line treated with AA or myx, suggesting that RCD1 acts as a modulator, not as a mediator, of the mitochondrial retrograde signal ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}).

To assess whether increased AOX abundance affected chloroplast functions, PSII inhibition was assayed in the presence of MV in AA- or myx-pre-treated leaf discs. Pre-treatment of Col-0 with either AA or myx increased the resistance of PSII to inhibition by chloroplastic ROS ([Figure 4D](#fig4){ref-type="fig"}), thus mimicking the *rcd1* phenotype. In addition to complex III, AA has been reported to inhibit plastid cyclic electron flow dependent on PGR5 (PROTON GRADIENT REGULATION 5). Thus, *pgr5* mutant was tested for its tolerance to chloroplastic ROS after AA pre-treatment. AA made *pgr5* more MV-tolerant similarly to the wild type, indicating that PGR5 is not involved in the observed gain in ROS tolerance ([Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}).

Mitochondrial complex III signaling induces expression of several genes other than *AOX*. To test whether accumulation of AOXs contributed to PSII protection from chloroplastic ROS or merely correlated with it, the AOX inhibitor salicylhydroxamic acid (SHAM) was used. Treatment of plants with SHAM alone resulted in very mild PSII inhibition, which was similar in *rcd1* and Col-0 ([Figure 4---figure supplement 3B](#fig4s3){ref-type="fig"}). However, pre-treatment with SHAM made both *rcd1* and Col-0 plants significantly more sensitive to chloroplastic ROS generated by MV ([Figure 4E](#fig4){ref-type="fig"}), thereby partially abolishing MV tolerance of the *rcd1* mutant. Involvement of the plastid terminal oxidase PTOX ([@bib32]) in this effect was excluded by using the *ptox* mutant ([Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}). Noteworthy, analyses of *AOX1a*-OE, *aox1a* and *rcd1 aox1a* lines demonstrated that AOX1a isoform was neither sufficient nor necessary for chloroplast ROS tolerance ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). Taken together, these results indicated that mitochondrial AOXs contributed to resistance of PSII to chloroplastic ROS. We hypothesize that AOX isoforms other than AOX1a are implicated in this process.

Evidence for altered electron transfer between chloroplasts and mitochondria in *rcd1* {#s2-5}
--------------------------------------------------------------------------------------

The pathway linking mitochondrial AOXs with chloroplastic ROS processing is likely to involve electron transfer between the two organelles. Chlorophyll fluorescence under light (Fs; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) inversely correlates with the rate of electron transfer from PSII to plastoquinone and thus can be used as a proxy of the reduction state of the chloroplast ETC. After combined treatment with SHAM and MV (as in [Figure 4E](#fig4){ref-type="fig"}), Fs increased in *rcd1*, but not in Col-0 ([Figure 5A](#fig5){ref-type="fig"}). This hinted that a pathway in *rcd1* linked the chloroplast ETC to the activity of mitochondrial AOXs, with the latter functioning as an electron sink. When the AOX activity was inhibited by SHAM, electron flow along this pathway was blocked. This led to accumulation of electrons in the chloroplast ETC and hence to the observed rise in Fs. As a parallel approach, dynamics of PSII photochemical quenching was evaluated in MV-pre-treated Col-0 and *rcd1*. In both lines, this parameter dropped within the first 20 min upon exposure to light and then started to recover. Recovery was more pronounced and more suppressed by SHAM in *rcd1* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). These experiments suggest that exposure of MV-pretreated plants to light triggered an adjustment of electron flows, which was compromised by SHAM. This was in line with the involvement of AOXs in photosynthetic electron transfer and chloroplast ROS maintenance.

![Altered electron transfer between the organelles in *rcd1*.\
(**A**) Leaf discs were pre-treated with 1 μM MV or MV plus 2 mM SHAM for 1 hr in the darkness. Then light was turned on (80 µmol m^−2^ s^−1^) and chlorophyll fluorescence under light (Fs) was recorded by Imaging PAM. Application of the two chemicals together caused Fs rise in *rcd1*, but not Col-0, suggesting increase in the reduction state of the chloroplast ETC in *rcd1*. For analysis of photochemical quenching see [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. (**B**) Malate levels are significantly decreased in Col-0 but not in *rcd1* after MV treatment in light. Malate level was measured in extracts from Col-0 and *rcd1* seedlings that were pre-treated overnight with 50 μM MV or water control and collected either dark-adapted or after exposure to 4 hr of light. Mean ±SE are shown. Asterisks indicate values significantly different from those in the similarly treated wild type, \*\*\*P value \< 0.001, \*\*P value \< 0.01, Student's t-test). For statistics, see [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}. (**C**) NADPH-MDH activity is increased in *rcd1*. To measure the activity of chloroplastic NADPH-MDH, plants were grown at 100--120 µmol m^−2^ s^−1^ at an 8 hr day photoperiod, leaves were collected in the middle of the day and freeze-dried. The extracts were prepared in the buffer supplemented with 250 μM thiol-reducing agent DTT, and initial activity was measured (top left). The samples were then incubated for 2 hr in the presence of additional 150 mM DTT, and total activity was measured (top right). The activation state of NADPH-MDH (bottom) is presented as the ratio of the initial and the total activity. Mean ±SE are shown. Asterisks indicate values significantly different from the wild type, \*\*P value \< 0.01, \*P value \< 0.05, Student's t-test. For statistics, see [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}.\
10.7554/eLife.43284.025Figure 5---source data 1.Source data and statistics.](elife-43284-fig5){#fig5}

One of the mediators of electron transfer between the organelles is the malate shuttle ([@bib97]; [@bib128]). Thus, malate concentrations were measured in total extracts from Col-0 and *rcd1* seedlings. Illumination of seedlings pre-treated with MV led to dramatic decrease in malate concentration in Col-0, but not in *rcd1* ([Figure 5B](#fig5){ref-type="fig"}). Noteworthy, under standard light-adapted growth conditions, the concentration and the subcellular distribution of malate was unchanged in *rcd1* ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). These observations suggest that exposure to light of MV-pre-treated plants resulted in rearrangements of electron flows that were different in Col-0 and *rcd1*.

Next, the activity of another component of the malate shuttle, the NADPH-dependent malate dehydrogenase (NADPH-MDH), was measured. Chloroplast NADPH-MDH is a redox-regulated enzyme activated by reduction of thiol bridges. Thus, the initial NADPH-MDH activity may reflect the in vivo thiol redox state of the cellular compartment from which it has been isolated. After measuring this parameter, thiol reductant was added to the extracts to reveal the total NADPH-MDH activity. Both values were higher in *rcd1* than in Col-0 ([Figure 5C](#fig5){ref-type="fig"}). To determine the contribution of in vivo thiol redox state, the initial NADPH-MDH activity was divided by the total activity. This value, the activation state, was also increased in *rcd1* ([Figure 5C](#fig5){ref-type="fig"}).

Taken together, our results suggested that mitochondria contributed to ROS processing in the chloroplasts *via* a mechanism involving mitochondrial AOXs and possibly the malate shuttle. These processes appeared to be dynamically regulated in response to chloroplastic ROS production, and RCD1 was involved in this regulation.

Retrograde signaling from both chloroplasts and mitochondria is altered in *rcd1* {#s2-6}
---------------------------------------------------------------------------------

Our results demonstrated that absence of RCD1 caused physiological alterations in both chloroplasts and mitochondria. As RCD1 is a nuclear-localized transcriptional co-regulator ([@bib50]; [@bib51]), its involvement in retrograde signaling pathways from both organelles was assessed. Transcriptional changes observed in *rcd1* ([@bib50]; [@bib10]) were compared to gene expression datasets obtained after perturbations in energy organelles. This revealed a striking similarity of genes differentially regulated in *rcd1* to those affected by disturbed organellar function ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Analyzed perturbations included disruptions of mitochondrial genome stability (*msh1 recA3*), organelle translation (*mterf6*, *prors1*), activity of mitochondrial complex I (*ndufs4*, rotenone), complex III (AA), and ATP synthase function (oligomycin), as well as treatments and mutants related to chloroplastic ROS production (high light, MV, H~2~O~2~, *alx8*/*fry1*, norflurazon).

In particular, a significant overlap was observed between genes mis-regulated in *rcd1* and the mitochondrial dysfunction stimulon (MDS) genes ([@bib23]) ([Figure 6A](#fig6){ref-type="fig"}). Consistently, *AOX1a* was among the genes induced by the majority of the treatments. To address the role of RCD1 protein in the induction of other MDS genes, mRNA steady state levels for some of them were assayed 3 hr after AA treatment ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). As expected, expression of all these genes was elevated in *rcd1* under control conditions. Treatment with AA induced accumulation of MDS transcripts to similar levels in Col-0, *rcd1*, and in *rcd1*: RCD1-HA lines that expressed low levels of RCD1. For one marker gene, *UPOX* (*UP-REGULATED BY OXIDATIVE STRESS*), AA induction was impaired in the lines expressing high levels of RCD1-HA or RCD1Δ7Cys-HA ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}).

![RCD1 is involved in mitochondrial dysfunction, chloroplast ROS and PAP signaling pathways.\
(**A**) Regulation of *rcd1* mis-expressed genes under perturbations of organellar functions in the selected subset of genes. A complete list of *rcd1*-misexpressed genes is presented in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. Similar transcriptomic changes are observed between the genes differentially regulated in *rcd1* and the genes affected by disturbed chloroplastic or mitochondrial functions. Mitochondrial dysfunction stimulon (MDS) genes regulated by ANAC013/ANAC017 transcription factors, are labeled green. (**B**) Sulfotransferase SOT12 encoded by an MDS gene accumulated in *rcd1* under standard growth conditions, as revealed by immunoblotting with the specific antibody. (**C**) Phenotype of the *rcd1 sal1* double mutant under standard growth conditions (12 hr photoperiod with white luminescent light of 220--250 µmol m^−2^ s^−1^).\
10.7554/eLife.43284.030Figure 6---source data 1.Source data and statistics.](elife-43284-fig6){#fig6}

In addition to MDS, the list of genes mis-regulated in *rcd1* overlapped with those affected by 3\'-phosphoadenosine 5\'-phosphate (PAP) signaling ([@bib27]; [@bib114]) ([Figure 6A](#fig6){ref-type="fig"}). Given that PAP signaling is suppressed by the activity of SAL1, expression of PAP-regulated genes was increased in the mutants deficient in SAL1 (*alx8* and *fry1*, [Figure 6A](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). One of the MDS genes with increased expression in *rcd1* encoded the sulfotransferase SOT12, an enzyme generating PAP. Accordingly, immunoblotting of total protein extracts with αSOT12 antibody demonstrated elevated SOT12 protein abundance in *rcd1* ([Figure 6B](#fig6){ref-type="fig"}). To address the functional interaction of RCD1 with PAP signaling, *rcd1-4* was crossed with *alx8* (also known as *sal1-8*). The resulting *rcd1 sal1* mutant was severely affected in development ([Figure 6C](#fig6){ref-type="fig"}). The effect of PAP signaling on the tolerance of PSII to chloroplastic ROS production was tested. The single *sal1* mutant was more tolerant to MV than Col-0, while under high MV concentration *rcd1 sal1* was even more MV-tolerant than *rcd1* ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}). Together with transcriptomic similarities between *rcd1* and *sal1* mutants, these results further supported an overlap and/or synergy of PAP and RCD1 signaling pathways.

RCD1 interacts with ANAC transcription factors in vivo {#s2-7}
------------------------------------------------------

Expression of the MDS genes is regulated by the transcription factors ANAC013 and ANAC017 ([@bib23]). The ANAC-responsive *cis*-element ([@bib23]) was significantly enriched in promoter regions of *rcd1* mis-regulated genes ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This suggested a functional connection between RCD1 and transcriptional regulation of the MDS genes by ANAC013/ANAC017. In an earlier study, ANAC013 was identified among many transcription factors interacting with RCD1 in the yeast two-hybrid system ([@bib50]). This prompted us to investigate further the connection between RCD1 and ANAC013 and the in vivo relevance of this interaction.

Association of RCD1 with ANAC transcription factors in vivo was tested in two independent pull-down experiments. To identify interaction partners of ANAC013, an Arabidopsis line expressing ANAC013-GFP ([@bib23]) was used. ANAC013-GFP was purified with αGFP beads, and associated proteins were identified by mass spectrometry in three replicates. RCD1 and its closest homolog SRO1, as well as ANAC017, were identified as ANAC013 interacting proteins (see [Table 1](#table1){ref-type="table"} for a list of selected nuclear-localized interaction partners of ANAC013, and [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"} for the full list of identified proteins and mapped peptides). These data confirmed that ANAC013, RCD1 and ANAC017 are components of the same protein complex in vivo. In a reciprocal pull-down assay using transgenic Arabidopsis line expressing RCD1 tagged with triple Venus YFP under the control of *UBIQUITIN10* promoter, RCD1-3xVenus and interacting proteins were immunoprecipitated using αGFP ([Table 1](#table1){ref-type="table"}; [Figure 7---source data 2](#fig7sdata2){ref-type="supplementary-material"}). ANAC017 was found among RCD1 interactors.

10.7554/eLife.43284.031

###### Overview of the immunoprecipitation results.

Selected proteins identified in ANAC013-GFP and RCD1-3xVenus pull-down assays. Ratio vs. Col-0 and the P-value were obtained by Perseus statistical analysis from the three repeats for each genotype used. Bold text indicates baits. The peptide coverage for selected proteins as well as full lists of identified proteins are presented in [Figure 7---source datas 1](#fig7sdata1){ref-type="supplementary-material"} and [2](#fig7sdata2){ref-type="supplementary-material"}.

  Ratio* vs*. Col-0              P-value             Unique peptides   Gene            Name          Stickiness
  ------------------------------ ------------------- ----------------- --------------- ------------- ------------
  ***ANAC013-GFP pull-down***                                                                        
  **50966**                      **7.09 × 10^−7^**   **29**            **AT1G32870**   **ANAC013**   
  **22149**                      **3.41 × 10^−8^**   **25**                            **GFP**       
  10097                          3.67 × 10^−6^       37                AT1G32230       RCD1          1.00%
  110                            1.67 × 10^−6^       8                 AT2G35510       SRO1          1.00%
  74                             1.09 × 10^−9^       4                 AT1G34190       ANAC017       1.00%
  ***RCD1-3xVenus pull-down***                                                                       
  **7593**                       **0.000454**        **35**            **AT1G32230**   **RCD1**      
  **1292**                       **0.006746**        **10**                            **YFP**       
  108                            5.48 × 10^−8^       2                 AT1G34190       ANAC017       1.00%

To test whether RCD1 directly interacts with ANAC013/ANAC017 in vivo, the complex was reconstituted in the human embryonic kidney cell (HEK293T) heterologous expression system (details in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Together with the results of in vivo pull-down assays, these experiments strongly supported the formation of a complex between RCD1 and ANAC013/ANAC017 transcription factors.

Structural and functional consequences of RCD1-ANAC interaction {#s2-8}
---------------------------------------------------------------

RCD1 interacts with many transcription factors belonging to different families ([@bib50]; [@bib51]; [@bib109]; [@bib11]) *via* its RST domain. The strikingly diverse set of RCD1 interacting partners may be partially explained by disordered flexible regions present in the transcription factors ([@bib63]; [@bib87]; [@bib11]). To address structural details of this interaction, the C-terminal domain of RCD1 (residues 468--589) including the RST domain (RST~RCD1~; 510--568) was purified and labeled with ^13^C and ^15^N for NMR spectroscopic study ([@bib106]) (details in [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"} and [Figure 7---source data 3](#fig7sdata3){ref-type="supplementary-material"}). ANAC013 was shown to interact with RCD1 in yeast two-hybrid assays ([@bib50]; [@bib87]). Thus, ANAC013^235-284^ peptide was selected to address the specificity of the interaction of the RST domain with ANAC transcription factors using NMR (details in [Figure 7---figure supplement 3A,B](#fig7s3){ref-type="fig"}). Binding of RCD1^468-589^ to ANAC013^235-284^ caused profound changes in the HSQC spectrum of RCD1^468-589^ ([Figure 7A](#fig7){ref-type="fig"} and [Figure 7---figure supplement 3C](#fig7s3){ref-type="fig"}). These data supported a strong and specific binary interaction between the RCD1 RST domain and the ANAC013 transcription factor.

![RST domain of RCD1 binds to ANAC transcription factors and is necessary for RCD1 function in vivo.\
Source data and statistics are presented in [Figure 7---source data 4](#fig7sdata4){ref-type="supplementary-material"}. (**A**) Biochemical interaction of ANAC013 with the RST domain of RCD1 in vitro. Superimposed ^1^H, ^15^N HSQC spectra of the C-terminal domain of RCD1 acquired in absence (blue) and presence (red) of approximately two-fold excess of the ANAC013^235-284^ peptide. Interaction of RCD1^468-589^ with ANAC013^235-284^ caused peptide-induced chemical shift changes in the ^1^H, ^15^N correlation spectrum of RCD1, which were mapped on the structure of the RST domain (inset). Inset: RST~RCD1~ structure with highlighted residues demonstrating the largest chemical shift perturbations (Δδ ≥ 0.10 ppm) between the free and bound forms (details in [Figure 7---figure supplement 3C](#fig7s3){ref-type="fig"}), which probably corresponds to ANAC013-interaction site. (**B**) Stable expression in *rcd1* of the HA-tagged RCD1 variant lacking its C-terminus under the control of the native *RCD1* promoter does not complement *rcd1* phenotypes. In the independent complementation lines RCD1ΔRST-HA was expressed at the levels comparable to those in the RCD1-HA lines (upper panel). However, in *rcd1*: RCD1ΔRST-HA lines abundance of AOXs (middle panel) was similar to that in *rcd1*. (**C**) Tolerance of PSII to chloroplastic ROS was similar in the *rcd1*: RCD1ΔRST-HA lines and *rcd1*. For each PSII inhibition experiment, leaf discs from at least four individual rosettes were used. The experiment was performed three times with similar results. Mean ±SD are shown.\
10.7554/eLife.43284.036Figure 7---source data 1.In vivo interaction partners of ANAC013.From Arabidopsis line expressing ANAC013-GFP, ANAC013-GFP and associated proteins were purified with αGFP antibody and identified by mass spectrometry. Identified proteins (Perseus analysis, ANAC013) and mapped peptides (peptide IDs) are shown.\
10.7554/eLife.43284.037Figure 7---source data 2.In vivo interaction partners of RCD1.From Arabidopsis line expressing RCD1-3xVenus, RCD1-3xVenus and associated proteins were purified with αGFP antibody and identified by mass spectrometry. Identified proteins (Perseus analysis, RCD1) and mapped peptides (peptide IDs) are shown.\
10.7554/eLife.43284.038Figure 7---source data 3.NMR constraints and structural statistics for the ensemble of the 15 lowest-energy structures of RCD1 RST.\
10.7554/eLife.43284.039Figure 7---source data 4.Source data and statistics.](elife-43284-fig7){#fig7}

To evaluate the physiological significance of this interaction, stable *rcd1* complementation lines expressing an HA-tagged RCD1 variant lacking the C-terminus (amino acids 462--589) were generated. The *rcd1*: RCD1ΔRST-HA lines were characterized by increased accumulation of AOXs in comparison with the *rcd1*: RCD1-HA lines ([Figure 7B](#fig7){ref-type="fig"}). They also had *rcd1*-like tolerance of PSII to chloroplastic ROS ([Figure 7C](#fig7){ref-type="fig"}).

Physiological outcomes of the interaction between RCD1 and ANAC transcription factors were further tested by reverse genetics. ANAC017 regulates the expression of *ANAC013* in the mitochondrial retrograde signaling cascade ([@bib112]). Since ANAC017 precedes ANAC013 in the regulatory pathway and because no *anac013* knockout mutant is available, only the *rcd1-1 anac017* double mutant was generated. In the double mutant curly leaf habitus of *rcd1* was partially suppressed ([Figure 8A](#fig8){ref-type="fig"}). The *rcd1-1 anac017* mutant was more sensitive to chloroplastic ROS than the parental *rcd1* line ([Figure 8B](#fig8){ref-type="fig"}). The double mutant was characterized by lower abundance of AOX isoforms ([Figure 8C](#fig8){ref-type="fig"}), dramatically decreased expression of MDS genes ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}) and lower AOX respiration capacity ([Figure 8D](#fig8){ref-type="fig"}) compared to *rcd1*. Thus, gene expression, developmental, chloroplast- and mitochondria-related phenotypes of *rcd1* were partially mediated by ANAC017. These observations suggested that the in vivo interaction of RCD1 with ANAC transcription factors, mediated by the RCD1 C-terminal RST domain, is necessary for regulation of mitochondrial respiration and chloroplast ROS processing.

![Developmental, chloroplast- and mitochondria-related phenotypes of *rcd1* are partially mediated by ANAC017.\
Source data and statistics are presented in [Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"}. (**A**) Introducing *anac017* mutation in the *rcd1* background partially suppressed the curly leaf phenotype of *rcd1*. (**B**) The *anac017* mutation partially suppressed tolerance of *rcd1* to chloroplastic ROS. PSII inhibition by ROS was measured in *rcd1 anac017* double mutant by using 0.25 μM or 1 μM MV (left and right panel, accordingly). For each experiment, leaf discs from at least four individual rosettes were used. The experiment was performed three times with similar results. Mean ±SD are shown. Asterisks denote selected values that are significantly different (P value \< 0.001, two-way ANOVA with Bonferroni post hoc correction). (**C**) The *anac017* mutation partially suppressed mitochondrial phenotypes of *rcd1*. Total AOX protein levels were lowered in *rcd1 anac017* double mutant as compared to *rcd1* both after the overnight treatment with 2.5 μM AA and in the untreated control. (**D**) Oxygen uptake by *rcd1 anac017* seedlings was measured in the darkness in presence of mitochondrial respiration inhibitors as described in [Figure 4C](#fig4){ref-type="fig"}. The *rcd1 anac017* mutant demonstrated lower KCN-insensitive AOX respiration capacity than *rcd1*. Each measurement was performed on 10--15 pooled seedlings and repeated at least three times. Mean ±SD are shown. Asterisks denote selected values that are significantly different (P value \< 0.001, one-way ANOVA with Bonferroni post hoc correction).\
10.7554/eLife.43284.042Figure 8---source data 1.Source data and statistics.](elife-43284-fig8){#fig8}

Discussion {#s3}
==========

RCD1 integrates chloroplast and mitochondrial signaling pathways {#s3-1}
----------------------------------------------------------------

Plant chloroplasts and mitochondria work together to supply the cell with energy and metabolites. In these organelles, ROS are formed as by-products of the electron transfer chains (photosynthetic in chloroplasts and respiratory in mitochondria). ROS serve as versatile signaling molecules regulating many aspects of plant physiology such as development, stress signaling, systemic responses, and programmed cell death (PCD) ([@bib26]; [@bib85]; [@bib118]). This communication network also affects gene expression in the nucleus where numerous signals are perceived and integrated. However, the molecular mechanisms of the coordinated action of the two energy organelles in response to environmental cues are only poorly understood. Evidence accumulated in this and earlier studies revealed the nuclear protein RCD1 as a regulator of energy organelle communication with the nuclear gene expression apparatus.

The *rcd1* mutant displays alterations in both chloroplasts and mitochondria ([@bib33]; [@bib43]; [@bib50]; [@bib10]; [@bib45]), and transcriptomic outcomes of RCD1 inactivation share similarities with those triggered by disrupted functions of both organelles ([Figure 6](#fig6){ref-type="fig"}). The results here suggest that RCD1 forms inhibitory complexes with components of mitochondrial retrograde signaling in vivo. Chloroplastic ROS appear to exhibit a direct influence on redox state and stability of RCD1 in the nucleus. These properties position RCD1 within a regulatory system encompassing mitochondrial complex III signaling through ANAC013/ANAC017 transcription factors and chloroplastic signaling by H~2~O~2~. The existence of such an inter-organellar regulatory system, integrating mitochondrial ANAC013 and ANAC017-mediated signaling ([@bib23]; [@bib80]) with the PAP-mediated chloroplastic signaling ([@bib27]; [@bib16]; [@bib18]) has been previously proposed on the basis of transcriptomic analyses ([@bib114]). However, the underlying molecular mechanisms remained unknown. Based on our results we propose that RCD1 may function at the intersection of mitochondrial and chloroplast signaling pathways and act as a nuclear integrator of both PAP and ANAC013 and ANAC017-mediated retrograde signals.

RCD1 has been proposed to act as a transcriptional co-regulator because of its interaction with many transcription factors in yeast two-hybrid analyses ([@bib50]). The in vivo interaction of RCD1 with ANAC013 and ANAC017 revealed in this study ([Table 1](#table1){ref-type="table"}, [Figures 7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}) suggests that RCD1 modulates expression of the MDS, a set of ANAC013/ANAC017 activated nuclear genes mostly encoding mitochondrial components ([@bib23]). *ANAC013* itself is an MDS gene, thus mitochondrial signaling through ANAC013/ANAC017 establishes a self-amplifying loop. Transcriptomic and physiological data support the role of RCD1 as a negative regulator of these transcription factors ([Figures 6](#fig6){ref-type="fig"}--[8](#fig8){ref-type="fig"}). Thus, RCD1 is likely involved in the negative regulation of the ANAC013/ANAC017 self-amplifying loop and in downregulating the expression of MDS genes after their induction.

Induction of genes in response to stress is commonly associated with rapid inactivation of a negative co-regulator. Accordingly, the RCD1 protein was sensitive to treatments triggering or mimicking chloroplastic ROS production. MV and H~2~O~2~ treatment of plants resulted in rapid oligomerization of RCD1 ([Figure 2](#fig2){ref-type="fig"}). Involvement of chloroplasts is indicated by the fact that MV treatment led to redox changes of RCD1-HA only in light ([Figure 2B](#fig2){ref-type="fig"} and [Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}). In addition, little change was observed with the mitochondrial complex III inhibitors AA or myx ([Figure 4---figure supplement 2A,B](#fig4s2){ref-type="fig"}). Together with the fact that MDS induction was not compromised in the *rcd1* mutant ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}), this suggests that RCD1 may primarily function as a redox sensor of chloroplastic, rather than mitochondrial, ROS/redox signaling. In addition to fast redox changes, the overall level of RCD1 gradually decreased during prolonged (5 hr) stress treatments. This suggests several independent modes of RCD1 regulation at the protein level.

The complicated post-translational regulation of RCD1 is reminiscent of another prominent transcriptional co-regulator protein NONEXPRESSER OF PR GENES 1 (NPR1). NPR1 exists as a high molecular weight oligomer stabilized by intermolecular disulfide bonds between conserved cysteine residues. Accumulation of salicylic acid and cellular redox changes lead to the reduction of cysteines and release of NPR1 monomers that translocate to the nucleus and activate expression of defense genes ([@bib57]; [@bib76]; [@bib124]). Similar to NPR1, RCD1 has a bipartite nuclear localization signal and, in addition, a putative nuclear export signal between the WWE and PARP-like domains. Like NPR1, RCD1 has several conserved cysteine residues. Interestingly, mutation of seven interdomain cysteines in RCD1 largely eliminated the fast in vivo effect of chloroplastic ROS on redox state and stability of RCD1; however, it did not significantly alter the plant response to MV ([Figure 2](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1C,D](#fig2s1){ref-type="fig"}). This suggests that redox-dependent oligomerization of RCD1 may serve to fine-tune its activity.

MDS genes are involved in interactions between the organelles {#s3-2}
-------------------------------------------------------------

How the RCD1-dependent induction of MDS genes contributes to the energetic and signaling landscape of the plant cell remains to be investigated. Our results suggest that one component of this adaptation is the activity of mitochondrial alternative oxidases, which are part of the MDS regulon. Consequently, AOX proteins accumulate at higher amounts in *rcd1* ([Figure 4](#fig4){ref-type="fig"}). Pretreatment of wild type plants with complex III inhibitors AA or myx led to elevated AOX abundance coinciding with increased tolerance to chloroplastic ROS. Moreover, the AOX inhibitor SHAM made plants more sensitive to MV, indicating the direct involvement of AOX activity in the chloroplastic ROS processing. It thus appears that AOXs in the mitochondria form an electron sink that indirectly contributes to the oxidization of the electron acceptor side of PSI. In the *rcd1* mutant, this mechanism may be continuously active. The described inter-organellar electron transfer may decrease production of ROS by PSI (asterisk in [Figure 9](#fig9){ref-type="fig"}). Furthermore, chloroplastic ROS are considered the main electron sink for oxidation of chloroplast thiol enzymes ([@bib89]; [@bib116]; [@bib127]). Thus, the redox status of these enzymes could depend on the proposed inter-organellar pathway. This is in line with higher reduction of the chloroplast enzymes 2-CP and NADPH-MDH observed in *rcd1* ([Figure 1C](#fig1){ref-type="fig"} and [Figure 5C](#fig5){ref-type="fig"}).

![Hypothetical role of RCD1 in organelle signaling and energy metabolism.\
RCD1 is the direct suppressor of ANAC transcription factors that is itself subject to redox regulation. Chloroplastic ROS likely affect RCD1 protein redox state and abundance. Inactivation of RCD1 leads to induction of ANAC-controlled MDS regulon. Expression of MDS genes is possibly feedback-regulated *via* the PAP retrograde signaling (purple). Resulting activation of mitochondrial AOXs and other MDS components is likely to affect electron flows (red) and ROS signaling in mitochondria and in chloroplasts. Putative competition of AOX-directed electron transfer with the formation of ROS at PSI is labeled with an asterisk.](elife-43284-fig9){#fig9}

The malate shuttle was recently shown to mediate a chloroplast-to-mitochondria electron transfer pathway that caused ROS production by complex III and evoked mitochondrial retrograde signaling ([@bib126]; [@bib128]). Altered levels of malate and increased activity of NADPH-dependent malate dehydrogenase in *rcd1* ([Figure 5](#fig5){ref-type="fig"}) suggest that in this mutant the malate shuttle could act as an inter-organellar electron carrier.

Another MDS gene with more abundant mRNA levels in the *rcd1* mutant encodes sulfotransferase SOT12, an enzyme involved in PAP metabolism ([@bib58]). Accordingly, SOT12 protein level was significantly increased in the *rcd1* mutant ([Figure 6B](#fig6){ref-type="fig"}). Accumulation of SOT12 and similarities between transcript profiles of RCD1- and PAP-regulated genes suggest that PAP signaling is likely to be constitutively active in the *rcd1* mutant. Unbalancing this signaling by elimination of SAL1 leads to severe developmental defects, as evidenced by the stunted phenotype of the *rcd1 sal1* double mutant. Thus, the RCD1 and the PAP signaling pathways appear to be overlapping and somewhat complementary, but the exact molecular mechanisms remain to be explored.

RCD1 regulates stress responses and cell fate {#s3-3}
---------------------------------------------

The MDS genes represent only a fraction of genes showing differential regulation in *rcd1* ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This likely reflects the fact that RCD1 interacts with many other protein partners in addition to ANACs. The C-terminal RST domain of RCD1 was shown to interact with transcription factors belonging to DREB, PIF, ANAC, Rap2.4 and other families ([@bib50]; [@bib109]; [@bib45]; [@bib11]). Analyses of various transcription factors interacting with RCD1 revealed little structural similarity between their RCD1-interacting sequences ([@bib87]). The flexible structure of the C-terminal domain of RCD1 probably determines the specificity and ability of RCD1 to interact with those different transcription factors. This makes RCD1 a hub in the crosstalk of organellar signaling with hormonal, photoreceptor, immune and other pathways and a likely mechanism by which these pathways are integrated and co-regulated.

The changing environment requires plants to readjust continuously their energy metabolism and ROS processing. On the one hand, this happens because of abiotic stress factors such as changing light intensity or temperature. For example, a sunlight fleck on a shade-adapted leaf can instantly alter excitation pressure on photosystems by two orders of magnitude ([@bib2]). On the other hand, chloroplasts and mitochondria are implicated in plant immune reactions to pathogens, contributing to decisive checkpoints including PCD ([@bib99]; [@bib93]; [@bib126]; [@bib114]; [@bib128]). In both scenarios, perturbations of organellar ETCs may be associated with increased production of ROS. However, the physiological outcomes of the two situations can be opposite: acclimation in one case and cell death in the other. The existence of molecular mechanisms that unambiguously differentiate one type of response from the other has been previously suggested ([@bib107]; [@bib103]; [@bib114]). The ANAC017 transcription factor and MDS genes, as well as PAP signaling, were proposed as organelle-related components counteracting PCD during abiotic stress ([@bib114]). This suggests that RCD1 is involved in the regulation of the cell fate checkpoint. Accordingly, the *rcd1* mutant is resistant to a number of abiotic stress treatments ([@bib1]; [@bib33]; [@bib50]).

Interestingly, in contrast to its resistance to abiotic stress, *rcd1* is more sensitive to treatments related to biotic stress. The *rcd1* mutant was originally identified in a forward genetic screen for sensitivity to ozone ([@bib90]). Ozone decomposes in the plant cell wall to ROS mimicking formation of ROS by respiratory burst oxidases (RBOHs) in the course of plant immune reactions ([@bib53]; [@bib110]). The opposing roles of RCD1 in the cell fate may be related to its interaction with diverse transcription factor partners and/or different regulation of its stability and abundance. For example, transcriptomic analyses showed that under standard growth conditions, a cluster of genes associated with defense against pathogens had decreased expression in *rcd1* ([@bib10]), and no ANAC013/ANAC017 *cis*-element motif is associated with these genes ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). In agreement with its role in biotic stress, RCD1 is a target for a fungal effector protein that prevents the activation of plant immunity ([@bib123]).

Another possible factor determining varying roles of RCD1 in the cell fate is differential regulation of RCD1 protein function by ROS/redox signals emitted by different subcellular compartments. The sensitivity of RCD1 to chloroplastic ROS ([Figure 2](#fig2){ref-type="fig"}) can be interpreted as negative regulation of the pro-PCD component. We hypothesize that this inactivation can occur in environmental situations that require physiological adaptation rather than PCD. For example, an abrupt increase in light intensity can cause excessive electron flow in photosynthetic ETC and overproduction of reducing power. The resulting deficiency of PSI electron acceptors can lead to changes in chloroplastic ROS production, which *via* retrograde signaling might influence RCD1 stability and/or redox status, inhibiting its activity and thus affecting adjustments in nuclear gene expression ([Figure 9](#fig9){ref-type="fig"}). Among other processes, RCD1-mediated suppression of ANAC013/ANAC017 transcription factors is released, allowing the induction of the MDS regulon. The consequent expression of AOXs together with increased chloroplast-to-mitochondrial electron transfer is likely to provide electron sink for photosynthesis, which could suppress chloroplast ROS production and contribute to the plant's survival under a changing environment ([Figure 9](#fig9){ref-type="fig"}).

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                           Designation              Source or reference                                              Identifiers           Additional\
  or resource                                                                                                                                                       information
  ------------------------------------------------- ------------------------ ---------------------------------------------------------------- --------------------- -------------------------------------------
  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-4*                 NASC stock center                                                GK-229D11             \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-1*                 PMID: [11041881](https://www.ncbi.nlm.nih.gov/pubmed/11041881)                         \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *aox1a*                  PMID: [16299171](https://www.ncbi.nlm.nih.gov/pubmed/16299171)                         \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *AOX1a*-OE               PMID: [16299171](https://www.ncbi.nlm.nih.gov/pubmed/16299171)                         \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *ptox*                   PMID: [7920709](https://www.ncbi.nlm.nih.gov/pubmed/7920709)                           \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent (*Arabidopsis thaliana*, Col-0)   *anac017*                NASC stock center                                                SALK_022174           \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *sal1-8*                 PMID: [19170934](https://www.ncbi.nlm.nih.gov/pubmed/19170934)                         homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1 aox1a*             PMID: [24550736](https://www.ncbi.nlm.nih.gov/pubmed/24550736)                         \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-1 anac017*         this paper                                                                             \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-4 sal1-8*          this paper                                                                             \
                                                                                                                                                                    homozygous mutant plant line

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-4*: RCD1-HA        this paper                                                                             set of complementation plant lines

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-4:* RCD1-3xVenus   this paper                                                                             set of complementation plant lines

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-4*: RCD1Δ7Cys-HA   this paper                                                                             set of complementation plant lines

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    *rcd1-4*: RCD1ΔRST-HA    this paper                                                                             set of complementation plant lines

  Genetic reagent(*Arabidopsis thaliana*, Col-0)    ANAC013-GFP              PMID: [24045019](https://www.ncbi.nlm.nih.gov/pubmed/24045019)                         transgenic plant line

  Genetic reagent(*Arabidopsis thaliana*, *gl*1)    *pgr5*                   PMID: [12176323](https://www.ncbi.nlm.nih.gov/pubmed/12176323)                         homozygous mutant plant line

  Cell line (*Homo sapiens*)                        HEK293T                  ATCC                                                             ATCC CRL-3216         human embryonic kidney cell line

  Gene (*Homo sapiens*)                             HA-RCD1                  this paper                                                                             construct for expression in HEK293T cells

  Gene (*Homo sapiens*)                             ANAC013-myc              this paper                                                                             construct for expression in HEK293T cells

  Gene (*Homo sapiens*)                             ANAC017-myc              this paper                                                                             construct for expression in HEK293T cells

  Antibody                                          αHA                      Roche                                                            Roche 1 867 423 001   1: 2 000 for immunoblotting

  Antibody                                          αGFP                     Milteny Biotech                                                                        

  Antibody                                          αRCD1                    this paper                                                                             1: 500 for immunoblotting

  Antibody                                          αSOT12                   Dr. Saijaliisa Kangasjärvi                                       Agrisera AS16 3943    1: 500 for immunoblotting

  Peptide, recombinant protein                      ANAC013 peptides         Genecust                                                                               Synthetic peptides
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plants and mutants {#s4-1}
------------------

*Arabidopsis thaliana* adult plants were grown on soil (peat: vermiculite = 1:1) in white luminescent light (220--250 µmol m^−2^ s^−1^) at a 12 hr photoperiod. Seedlings were grown for 14 days on 1 x MS basal medium (Sigma-Aldrich) with 0.5% Phytagel (Sigma-Aldrich) without added sucrose in white luminescent light (150--180 µmol m^−2^ s^−1^) at a 12 hr photoperiod. Arabidopsis *rcd1-4* mutant (GK-229D11), *rcd1-1* ([@bib90]), *aox1a* (SAIL_030_D08), *AOX1a-*OE ([@bib108]), *ptox* ([@bib121]), *anac017* (SALK_022174), and *sal1-8* ([@bib122]) mutants are of Col-0 background; *pgr5* mutant is of *gl1* background ([@bib78]). ANAC013-GFP line is described in [@bib23], RCD1-HA line labeled '*a*' in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} is described in [@bib50], *rcd1 aox1a* double mutant -- in [@bib10]. RCD1-3xVenus, RCD1∆7Cys-HA, RCD1∆RST-HA lines are described in *Cloning*.

Cloning {#s4-2}
-------

The *rcd1* complementation line expressing RCD1 tagged with triple HA epitope on the C-terminus was described previously ([@bib50]). In this line the genomic sequence of RCD1 was expressed under the control of the *RCD1* native promotor (3505 bp upstream the start codon). The RCD1∆7Cys-HA construct was generated in the same way as RCD1-HA. The cysteine residues were mutated to alanines by sequential PCR-based mutagenesis of the genomic sequence of *RCD1* in the pDONR/Zeo vector followed by end-joining with In-Fusion (Clontech). The RCD1∆RST-HA variant was generated in the same vector by removal with a PCR reaction of the region corresponding to amino acid residues 462--589. The resulting construct was transferred to the pGWB13 binary vector by a Gateway reaction. To generate the RCD1-3xVenus construct, RCD1 cDNA was fused to the *UBIQUITIN10* promoter region and to the C-terminal triple Venus YFP tag in a MultiSite Gateway reaction as described in [@bib102]. The vectors were introduced in the *rcd1-4* mutant by floral dipping. Homozygous single insertion Arabidopsis lines were obtained. They were defined as the lines demonstrating 1:3 segregation of marker antibiotic resistance in T2 generation and 100% resistance to the marker antibiotic in T3 generation.

For HEK293T cell experiments codon-optimized N-terminal 3xHA-fusion of RCD1 and C-terminal 3xmyc-fusion of ANAC013 were cloned into pcDNA3.1(+). Full-length ANAC017 was cloned into pcDNA3.1(-) in the Xho I/Hind III sites, the double myc tag was introduced in the reverse primer sequence. The primer sequences used for the study are presented in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Generation of the αRCD1 antibody {#s4-3}
--------------------------------

αRCD1 specific antibody was raised in rabbit using denatured RCD1-6His protein as the antigen for immunization (Storkbio, Estonia). The final serum was purified using denatured RCD1-6His immobilized on nitrocellulose membrane, aliquoted and stored at −80°C. For immunoblotting, 200 μg of total protein were loaded per well, the antibody was used in dilution 1: 500.

Inhibitor treatments {#s4-4}
--------------------

For PSII inhibition studies, leaf discs were let floating on Milli-Q water solution supplemented with 0.05% Tween 20 (Sigma-Aldrich). Final concentration of AA and myx was 2.5 μM each, of SHAM -- 2 mM. For transcriptomic experiments, plant rosettes were sprayed with water solution of 50 μM AA complemented with 0.01% Silwet Gold (Nordisk Alkali). Stock solutions of these chemicals were prepared in DMSO, equal volumes of DMSO were added to control samples. Pre-treatment with chemicals was carried out in the darkness, overnight for MV, AA and myx, 1 hr for SHAM. After spraying plants with 50 μM AA they were incubated in growth light for 3 hr. For chemical treatment in seedlings grown on MS plates, 5 mL of Milli-Q water with or without 50 µM MV were poured in 9 cm plates at the end of the light period. The seedlings were kept in the darkness overnight, and light treatment was performed on the following morning. For H~2~O~2~ treatment, the seedlings were incubated in 5 mL of Milli-Q water with or without 100 mM H~2~O~2~ in light.

DAB staining {#s4-5}
------------

Plant rosettes were stained with 3,3′-diaminobenzidine (DAB) essentially as described in [@bib22]. After vacuum infiltration of DAB-staining solution in the darkness, rosettes were exposed to light (180 µmol m^−2^ s^−1^) for 20 min to induce production of chloroplastic ROS and then immediately transferred to the bleaching solution.

Spectroscopic measurements of photosynthesis {#s4-6}
--------------------------------------------

Chlorophyll fluorescence was measured by MAXI Imaging PAM (Walz, Germany). PSII inhibition protocol consisted of repetitive 1 hr periods of blue actinic light (450 nm, 80 µmol m^−2^ s^−1^) each followed by a 20 min dark adaptation, then Fo and Fm measurement. PSII photochemical yield was calculated as Fv/Fm = (Fm-Fo)/Fm ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). To plot raw chlorophyll fluorescence kinetics under light (Fs) against time, the reads were normalized to dark-adapted Fo. For the measurements of photochemical quenching, Fm' was measured with saturating pulses triggered against the background of actinic light (450 nm, 80 µmol m^−2^ s^−1^), and the following formulae were used: qP = (Fm\' - Fs)/(Fm\'-Fo\'), where Fo\' ≈ Fo / (((Fm -- Fo)/Fm) + (Fo/Fm\')) ([@bib91]). The assays were performed in 96-well plates. In each assay, leaf discs from at least four individual plants were analyzed. Each assay was reproduced at least three times.

PSI (P700) oxidation was measured by DUAL-PAM-100 (Walz, Germany) as described ([@bib105]). Leaves were pre-treated in 1 µM MV for 4 hr, then shifted to light (160 µmol m^−2^ s^−1^) for indicated time. Oxidation of P700 was induced by PSI-specific far red light (FR, 720 nm). To determine fully oxidized P700 (Pm), a saturating pulse of actinic light was applied under continuous background of FR, followed by switching off both the actinic and FR light. The kinetics of P700^+^ reduction by intersystem electron transfer pool and re-oxidation by FR was determined by using a multiple turnover saturating flash of PSII light (635 nm) in the background of continuous FR.

Isolation, separation and detection of proteins and protein complexes {#s4-7}
---------------------------------------------------------------------

Thylakoids were isolated as described in [@bib49]. Chlorophyll content was determined according to [@bib94] and protein content according to [@bib73]. For immunoblotting of total plant extracts, the plant material was frozen immediately after treatments in liquid nitrogen and ground. Total proteins were extracted in SDS extraction buffer \[50 mM Tris-HCl (pH 7.8), 2% SDS, 1 x protease inhibitor cocktail (Sigma-Aldrich), 2 mg/mL NaF\] for 20 min at 37°C and centrifuged at 18 000 x *g* for 10 min. Supernatants were normalized for protein concentration and resolved by SDS-PAGE. For separation of proteins, SDS-PAGE (10--12% polyacrylamide) was used ([@bib67]). For thylakoid proteins, the gel was complemented with 6 M urea. To separate thylakoid membrane protein complexes, isolated thylakoids were solubilized with *n*-dodecyl β-D-maltoside (Sigma-Aldrich) and separated in BN-PAGE (5--12.5% polyacrylamide) as described by [@bib49]. After electrophoresis, proteins were electroblotted to PVDF membrane and immunoblotted with specific antibodies. αSOT12 antibodies have Agrisera reference number AS16 3943. For quantification of immunoblotting signal, ImageJ software was used (<https://imagej.nih.gov/ij/>).

Analysis of protein thiol redox state by mobility shift assays {#s4-8}
--------------------------------------------------------------

Thiol redox state of 2-CPs in detached Col-0 and *rcd1* leaves adapted to darkness or light (3 hr of 160 µmol m^−2^ s^−1^), was determined by alkylating free thiols in TCA-precipitated proteins with 50 mM N-ethylmaleimide in the buffer containing 8 M urea, 100 mM Tris‐HCl (pH 7.5), 1 mM EDTA, 2% SDS, and 1/10 of protease inhibitor cocktail (Thermo Scientific), reducing in vivo disulfides with 100 mM DTT and then alkylating the newly reduced thiols with 10 mM methoxypolyethylene glycol maleimide of molecular weight 5 kDa (Sigma-Aldrich), as described in [@bib83]. Proteins were then separated by SDS-PAGE and immunoblotted with a 2-CP-specific antibody.

Non-aqueous fractionation (NAF) {#s4-9}
-------------------------------

Leaves of Arabidopsis plants were harvested in the middle of the light period and snap-frozen in liquid nitrogen. Four grams of fresh weight of frozen plant material was ground to a fine powder using a mixer mill (Retsch), transferred to Falcon tubes and freeze-dried at 0.02 bar for 5 days in a lyophilizer, which had been pre-cooled to −40°C. The NAF-fractionation procedure was performed as described in [@bib64], [@bib4], and [@bib65], except that the gradient volume, composed of the solvents tetrachloroethylene (C~2~Cl~4~)/heptane (C~7~H~16~), was reduced from 30 mL to 25 mL but with the same linear density. Leaf powder was resuspended in 20 mL C~2~Cl~4~/C~7~H~16~ mixture 66:34 (v/v; density ρ = 1.3 g cm^−3^), and sonicated for 2 min, with 6 × 10 cycles at 65% power. The sonicated suspension was filtered through a nylon net (20 μm pore size). The net was washed with 30 mL of heptane. The suspension was centrifuged for 10 min at 3 200 x *g* at 4°C and the pellet was resuspended in 5 mL C~2~Cl~4~/C~7~H~16~ mixture 66:34. The gradient was formed in 38 mL polyallomer centrifugation tube using a peristaltic gradient pump (BioRad) generating a linear gradient from 70% solvent A (C~2~Cl~4~/C~7~H~16~ mixture 66:34) to 100% solvent B (100% C~2~Cl~4~) with a flow rate of 1.15 mL min^−1^, resulting in a density gradient from 1.43 g cm^−3^ to 1.62 g cm^−3^. Five mL suspension containing the sample was loaded on top of the gradient and centrifuged for 55 min at 5 000 x *g* at 4°C using a swing-out rotor with acceleration and deceleration of 3:3 (brakes off). Each of the compartment-enriched fractions (F1 to F8) were transferred carefully from the top of the gradient into a 50 mL Falcon tube, filled up with heptane to a volume of 20 mL and centrifuged at 3 200 x *g* for 10 min. The pellet was resuspended in 6 mL of heptane and subsequently divided into 6 aliquots of equal volume (950 μL). The pellets had been dried in a vacuum concentrator without heating and stored at −80°C until further use. Subcellular compartmentation of markers or the metabolites of our interest was calculated by BestFit method as described in [@bib64] and [@bib65]. Percentage values (% of the total found in all fractions) of markers and metabolites have been used to make the linear regressions for subcellular compartments using BestFit.

Marker measurements for non-aqueous fractionation {#s4-10}
-------------------------------------------------

Before enzyme and metabolite measurements, dried pellets were homogenized in the corresponding extraction buffer by the addition of one steel ball (2 mm diameter) to each sample and shaking at 25 Hz for 1 min in a mixer mill. Enzyme extracts were prepared as described in [@bib38] with some modifications. The extraction buffer contained 50 mM HEPES-KOH (pH 7.5), 10 mM MgCl~2~, 1 mM EDTA, 1 mM EGTA, 1 mM benzamidine, 1 mM ε-aminocaproic acid, 0.25% (w/v) BSA, 20 μM leupeptin, 0.5 mM DTT, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1% (v/v) Triton X-100, 20% glycerol. The extract was centrifuged (14 000 rpm at 4°C for 10 min) and the supernatant was used directly for the enzymatic assays. The activities of adenosine diphosphate glucose pyrophosphorylase (AGPase) and phosphoenolpyruvate carboxylase (PEPC) were determined as described in [@bib38] but without using the robot-based platform. Chlorophyll was extracted twice with 80% (v/v) and once with 50% (v/v) hot ethanol/10 mM HEPES (pH 7.0) followed by 30 min incubation at 80°C and determined as described in [@bib19]. Nitrate was measured by the enzymatic reaction as described in [@bib19].

Incubation of Arabidopsis leaf discs with \[U-^14^C\] glucose {#s4-11}
-------------------------------------------------------------

For the light experiment, leaf discs were incubated in light in 5 mL 10 mM MES-KOH (pH 6.5), containing 1.85 MBq/mmol \[U-^14^C\] glucose (Hartmann Analytic) in a final concentration of 2 mM. In the dark experiment, leaf discs were incubated under green light for 150 min. Leaf discs were placed in a sieve, washed several times in double-distilled water, frozen in liquid nitrogen, and stored at −80°C until further analysis. All incubations were performed in sealed flasks under green light and shaken at 100 rpm. The evolved ^14^CO~2~ was collected in 0.5 mL of 10% (w/v) KOH.

Fractionation of ^14^C-labeled tissue extracts and measurement of metabolic fluxes {#s4-12}
----------------------------------------------------------------------------------

Extraction and fractionation were performed according to [@bib88]. Frozen leaf discs were extracted with 80% (v/v) ethanol at 80°C (1 mL per sample) and re-extracted in two subsequent steps with 50% (v/v) ethanol (1 mL per sample for each step), and the combined supernatants were dried under an air stream at 35°C and resuspended in 1 mL of water ([@bib30]). The soluble fraction was subsequently separated into neutral, anionic, and basic fractions by ion-exchange chromatography; the neutral fraction (2.5 mL) was freeze-dried, resuspended in 100 μL of water, and further analyzed by enzymatic digestion followed by a second ion-exchange chromatography step ([@bib14]). To measure phosphate esters, samples (250 μL) of the soluble fraction were incubated in 50 μL of 10 mM MES-KOH (pH 6.0), with or without 1 unit of potato acid phosphatase (grade II; Boehringer Mannheim) for 3 hr at 37°C, boiled for 2 min, and analyzed by ion-exchange chromatography ([@bib30]). The insoluble material left after ethanol extraction was homogenized, resuspended in 1 mL of water, and counted for starch ([@bib30]). Fluxes were calculated as described following the assumptions detailed by [@bib35] and [@bib36]. Unfortunately, the discontinued commercial availability of the required positionally radiolabeled glucoses prevented us from analyzing fermentative fluxes more directly.

Preparation of crude mitochondria {#s4-13}
---------------------------------

Crude mitochondria were isolated from Arabidopsis rosette leaves as described in [@bib56].

Measurements of AOX capacity in vivo {#s4-14}
------------------------------------

Seedling respiration and AOX capacity were assessed by measuring O~2~ consumption in the darkness using a Clark electrode as described in [@bib98].

Metabolite extraction {#s4-15}
---------------------

Primary metabolites were analyzed with GC-MS according to [@bib96]. GC-MS analysis was executed from the plant extracts of eight biological replicates (pooled samples). Plant material was homogenized in a Qiagen Tissuelyser II bead mill (Qiagen, Germany) with 1--1.5 mm Retsch glass beads. Soluble metabolites were extracted from plant material in two steps, first with 1 mL of 100% methanol (Merck) and second with 1 mL of 80% (v/v) aqueous methanol. During the first extraction step, 5 µL of internal standard solution (0.2 mg mL^−1^ of benzoic-d~5~ acid, 0.1 mg mL^−1^ of glycerol-d~8~, 0.2 mg mL^−1^ of 4-methylumbelliferone in methanol) was added to each sample. During both extraction steps, the samples were vortexed for 30 min and centrifuged for 5 min at 13 000 rpm (13 500 × *g*) at 4°C. The supernatants were then combined for metabolite analysis. The extracts (2 mL) were dried in a vacuum concentrator (MiVac Duo, Genevac Ltd, Ipswich, UK), the vials were degassed with nitrogen and stored at −80°C prior to derivatization and GC-MS analysis.

Dried extracts were re-suspended in 500 µL of methanol. Aliquot of 200 µL was transferred to a vial and dried in a vacuum. The samples were derivatized with 40 µL of methoxyamine hydrochloride (MAHC, Sigma-Aldrich) (20 mg mL^−1^) in pyridine (Sigma-Aldrich) for 90 min at 30°C at 150 rpm, and with 80 µL N-methyl-N-(trimethylsilyl) trifluoroacetamide with 1% trimethylchlorosilane (MSTFA with 1% TMCS, Thermo Scientific) for 120 min at 37°C at 150 rpm. Alkane series (10 µL, C10--C40, Supelco) in hexane (Sigma-Aldrich) and 100 µL of hexane was added to each sample before GC-MS analysis.

Metabolite analysis by gas chromatography-mass spectrometry {#s4-16}
-----------------------------------------------------------

The GC-MS system consisted of Agilent 7890A gas chromatograph with 7000 Triple quadrupole mass spectrometer and GC PAL autosampler and injector (CTC Analytics). Splitless injection (1 µL) was employed using a deactivated single tapered splitless liner with glass wool (Topaz, 4 mm ID, Restek). Helium flow in the column (Agilent HP-5MS Ultra Inert, length 30 m, 0.25 mm ID, 0.25 μm film thickness combined with Agilent Ultimate Plus deactivated fused silica, length 5 m, 0.25 mm ID) was 1.2 mL min^−1^ and purge flow at 0.60 min was 50 mL min^−1^. The injection temperature was set to 270°C, MS interface 180°C, source 230°C and quadrupole 150°C. The oven temperature program was as follows: 2 min at 50°C, followed by a 7 °C min^−1^ ramp to 260°C, 15 °C min^−1^ ramp to 325°C, 4 min at 325°C and post-run at 50°C for 4.5 min. Mass spectra were collected with a scan range of 55--550 *m/z*.

Metabolite Detector (versions 2.06 beta and 2.2N) ([@bib44]) and AMDIS (version 2.68, NIST) were used for deconvolution, component detection and quantification. Malate levels were calculated as the peak area of the metabolite normalized with the peak area of the internal standard, glycerol-d~8~, and the fresh weight of the sample.

Measurements of NADPH-MDH activity {#s4-17}
----------------------------------

From light-adapted plants grown for 5 weeks (100--120 µmol m^−2^ s^−1^ at an 8 hour day photoperiod), total extracts were prepared as for non-aqueous fractionation in the extraction buffer supplemented with 250 µM DTT. In microplates, 5 µL of the extract (diluted x 500) were mixed with 20 µL of activation buffer, 0.1 M Tricine-KOH (pH 8.0), 180 mM KCl, 0.5% Triton X-100). Initial activity was measured immediately after, while total activity was measured after incubation for 2 hr at room temperature in presence of additional 150 mM DTT. Then assay mix was added consisting of 20 µL of assay buffer \[0.5 M Tricine-KOH (pH 8.0), 0.25% Triton X-100, 0.5 mM EDTA\], 9 µL of water, and 1 µL of 50 mM NADPH (prepared in 50 mM NaOH), after which 45 µL of 2.5 mM oxaloacetate or water control was added. The reaction was mixed, and light absorbance at 340 nm wavelength was measured at 25°C.

Analysis of *rcd1* misregulated genes in microarray experiments related to chloroplast or mitochondrial dysfunction {#s4-18}
-------------------------------------------------------------------------------------------------------------------

Genes with misregulated expression in *rcd1* were selected from our previous microarray datasets ([@bib10]) with the cutoff, absolute value of logFC \<0.5. These genes were subsequently clustered with the *rcd1* gene expression dataset together with various Affymetrix datasets related to chloroplast or mitochondrial dysfunction from the public domain using bootstrapped Bayesian hierarchical clustering as described in [@bib125]. Affymetrix raw data (.cel files) were normalized with Robust Multi-array Average normalization, and manually annotated to control and treatment conditions, or mutant *versus* wild type.

Affymetrix ATH1-121501 data were from the following sources: Gene Expression Omnibus <https://www.ncbi.nlm.nih.gov/geo/>, AA 3 hr (in figures labelled as experiment 1), GSE57140 ([@bib47]); AA and H~2~O~2~, 3 hr treatments (in figures labelled as experiment 2), GSE41136 ([@bib80]); MV 3 hr, GSE41963 ([@bib100]); *mterf6-1*, GSE75824 ([@bib70]); *prors1-2*, GSE54573 ([@bib68]); H~2~O~2~ 30 min, GSE43551 ([@bib41]); high light 1 hr (in figures labelled as experiment 1), GSE46107 ([@bib111]); high light 30 min in cell culture, GSE22671 ([@bib40]); high light 3 hr (in figures labelled as experiment 2), GSE7743 ([@bib59]); oligomycin 1 and 4 hr, GSE38965 ([@bib37]); norflurazon -- 5 day-old seedlings grown on plates with norflurazon, GSE12887 ([@bib62]); *msh1 recA3* double mutant, GSE19603 ([@bib101]). AtGenExpress oxidative time series, MV 12 and 24 hr, <http://www.arabidopsis.org/servlets/TairObject?type=expression_set&id=1007966941>. ArrayExpress, <https://www.ebi.ac.uk/arrayexpress/>: rotenone, 3 and 12 hr, E-MEXP-1797 ([@bib34]); *alx8* and *fry1*, E-MEXP-1495 ([@bib122]); *ndufs4*, E-MEXP-1967 ([@bib74]).

Quantitative PCR {#s4-19}
----------------

Quantitative PCR was performed essentially as described in [@bib10]. The data were normalized with three reference genes, *PP2AA3*, *TIP41* and *YLS8*. Relative expression of the genes *RCD1*, *AOX1a*, *UPOX, ANAC013*, *At5G24640* and *ZAT12* was calculated in qBase +3.2 (Biogazelle, <https://www.qbaseplus.com/>). The primer sequences and primer efficiencies are presented in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Identification of interacting proteins using IP/MS-MS {#s4-20}
-----------------------------------------------------

Immunoprecipitation experiments were performed in three biological replicates as described previously ([@bib24]), using 3 g of rosette leaves from p35S: ANAC013-GFP and 2.5 g of rosette leaves from pUBI10: RCD1-3xVenus transgenic lines. Interacting proteins were isolated by applying total protein extracts to αGFP-coupled magnetic beads (Milteny Biotech). Three replicates of p35S: ANAC013-GFP or pUBI10: RCD1-3xVenus were compared to three replicates of Col-0 controls. Tandem mass spectrometry (MS) and statistical analysis using MaxQuant and Perseus software was performed as described previously ([@bib120]).

HEK293T human embryonic kidney cell culture and transfection {#s4-21}
------------------------------------------------------------

HEK293T cells were maintained at 37°C and 5% CO~2~ in Dulbecco's Modified Eagle's Medium F12-HAM, supplemented with 10% fetal bovine serum, 15 mM HEPES, and 1% penicillin/streptomycin. Cells were transiently transfected using GeneJuice (Novagen) according to the manufacturer's instructions.

For co-immunoprecipitation experiments, HEK293T cells were co-transfected with plasmids encoding HA-RCD1 and ANAC013-myc or ANAC017-myc. Forty hours after transfection, cells were lysed in TNE buffer \[50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 x protease inhibitor cocktail, 50 µM proteasome inhibitor MG132 (Sigma-Aldrich)\]. After incubation for 2 hr at 4°C, lysates were cleared by centrifugation at 18 000 x *g* for 10 min at 4°C. For co-immunoprecipitation, cleared cell lysates were incubated with either αHA or αmyc antibody immobilized on agarose beads overnight at 4°C. Beads were washed six times with the lysis buffer. The bound proteins were dissolved in SDS sample buffer, resolved by SDS-PAGE, and immunoblotted with the specified antibodies.

Protein expression and purification {#s4-22}
-----------------------------------

The C-terminal domain of RCD1 for NMR study was expressed as GST-fusion protein in *E.coli* BL21 (DE3) Codon Plus strain and purified using GSH-Sepharose beads (GE Healthcare) according to the manufacturer's instruction. Cleavage of GST tag was performed with thrombin (GE Healthcare, 80 units per mL of beads) for 4 hr at room temperature and the C-terminal domain of RCD1 was eluted from the beads with PBS buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, 1.8 mM KH~2~PO~4~, pH 7.4). The protein was further purified by gel filtration with HiLoad 16/600 Superdex 75 column (GE Healthcare) equilibrated with 20 mM sodium phosphate buffer (pH 6.4), 50 mM NaCl at 4°C.

Peptide synthesis {#s4-23}
-----------------

ANAC013 peptides of \>98% purity for surface plasmon resonance and NMR analysis were purchased from Genecust, dissolved in water to 5 mM final concentration and stored at −80°C before analyses.

Surface Plasmon resonance {#s4-24}
-------------------------

The C-terminal domain of RCD1 was covalently coupled to a Biacore CM5 sensor chip *via* amino-groups. 500 nM of ANAC013 peptides were then profiled at a flow rate of 30 µL min^−1^ for 300 s, followed by 600 s flow of running buffer. Analysis was performed at 25°C in the running buffer containing 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, 0.05% surfactant P20 (Tween-20). After analysis in BIAevaluation (Biacore) software, the normalized resonance units were plotted over time with the assumption of one-to-one binding.

NMR spectroscopy {#s4-25}
----------------

NMR sample production and chemical shift assignment have been described in [@bib106]. A Bruker Avance III HD 800 MHz spectrometer equipped with a TCI ^1^H/ ^13^C/ ^15^N cryoprobe was used to acquire spectra for structure determination of RCD1^468-589^. Peaks were manually picked from three NOE spectra, a ^1^H, ^15^N NOESY-HSQC and ^1^H, ^13^C NOESY-HSQC spectra for the aliphatic and aromatic ^13^C regions. CYANA 2.1 ([@bib72]) automatic NOE peak assignment -- structure calculation routine was used to generate 300 structures from which 30 were further refined in explicit water with AMBER 16 ([@bib15]). Assignments of three NOE peaks were kept fixed using the KEEP subroutine in CYANA. These NOE peaks restrained distances between the side chains of W507 and M508 and adjacent helices 1 and 4, respectively. Fifteen lowest AMBER energy structures were chosen to represent of RCD1^468-589^ structure in solution.

Peptide binding experiment was carried out by preparing a sample containing RCD1^468-589^ and ANAC013^235-284^ peptides in an approximately 1:2 concentration ratio, and recording a ^1^H, ^15^N HSQC spectrum. Amide peak positions were compared with those of the free RCD1^468-589^.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"RCD1 Coordinates Chloroplastic and Mitochondrial Electron Transfer through Interaction with ANAC Transcription Factors\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered for publication in *eLife* in its present form.

However, we would be ready to have a second look at a resubmission of a substantially revised manuscript that comprehensively addresses the reviewer comments, including the following key experiments:

1\) One important experiment would be to look for suppression of NAC17-dependent retrograde signalling in an RCD overexpression and/or RCD 7cys complemented line. Notably, these lines should be readily available, and as such these are not very challenging experiments.

2\) It must be clarified whether the initial MDH activity was indeed measured after 2 h of incubation in the absence of DTT, as it presently reads in subsection "Measurements of NADPH-MDH activity". This would have caused inactivation. If the non-aqueous fractions still exist, chloroplast malate levels would be most interesting rather than whole leaf amounts.

3\) Finally, the manuscript should be substantially rewritten and rearranged. In particular, you would have to streamline your paper and focus on the novel aspects. Confirmatory experiments with respect to the literature should receive less attention and be displayed in the extended data. Moreover, often the results can only be understood when investigating the figure, reading the legend, the corresponding section in the Materials and methods and the text passage. You should aim to ease this process. For example you could provide the most important information in the legend, e.g. the light intensity used for NADPH-MDH-activity measurement (Figure 3), the incubation time with MV in Figure 3B or the positions of standard polypeptides in the Western blots.

Reviewer \#1:

This paper reports on a complex but highly interesting story, based on the compilation of diverse data linking RADICAL CELL DEATH 1(RCD1) function with regulation of redox and reactive oxygen species signaling and brings this in the wider context of retrograde information exchange in photosynthetic cells. The effect of lacking RCD1 on AOX transcript accumulation is highly interesting and correlated with high accumulation of AOX1A. Inefficient ATP production by the respiratory chain in the mutants was compensated by increased activity of glycolysis and linked pathways such as oxidative pentose pathway.

The strength of the study is that the authors attempt to test their hypotheses by using specific mutants. Another important point is the establishment of the link between the RCD1-dependent signaling and ANAC13/ 17, physically (shown before) and now deepened for the proteins ANAC13/ ANAC17/ SRO1/ RCD1 (also in human embryonic kidney cell; these results could move to the supplementary materials), indirectly functionally by corresponding changes in the transcriptomes and by increased ROS sensitivity of rd1/anac17 double mutants. The structural part on the interaction between RCD1 and ANAC13/ 17 is also significant.

It has to be taken with caution that H~2~O~2~ and methylviologen treatments specifically mimic chloroplast ROS production. This must be discussed with more care, also in the Discussion final paragraph. Exogenous application of H~2~O~2~ acts in different cells and cell compartments, likewise MV supplementation is not a specific inducer of chloroplast ROS. Thus high light treatment affects analyzed parameters different to H~2~O~2~ and methylviologen.

Figure 3: Subsection "Evidence for increased electron transfer between chloroplasts and mitochondria in rcd1": The activation state of NADPH malate dehydrogenase (MDH) is very low, almost unbelievably low (4-8%). Doubling the activity from this very low activation state unlikely is sufficient to explain any changes in rcd1 mutants. Kinetic modelling could help to define whether the observation is significant or not. The legend to the figure is insufficient to understand what is measured. Describe the photosynthetic condition the leaves were exposed to here. The concern with this interpretation is strengthened by the unchanged NADPH/NADP-ratio in non-aqueously isolated chloroplasts. The incubation of the test with and without DTT for 2 h at room temperature is not clear: Was the minus DTT-sample supposed to be the initial activity? During a 2 h incubation with 250 μM DTT, the initially active MDH may inactivate and this may explain the extremely low activity? This ambiguity must be clarified. Possibly the measurements would have to be repeated if they are considered to be central to the paper.

The comfort of reading is not always optimal at present since the reader must simultaneously consult the text, the legend and the method.

The high concentrations of NADH and NADPH in the vacuole appears surprising and an artefact. The description of the method and results may not be complete here. Which other compartment markers were measured and included in the best fit? May be it would be more reliable and convincing to present total leaf nucleotide levels rather than somewhat questionable date on subcellular compartments. The statistically significant difference in vacuolar NADH points to severe problems with this method.

The discussion is mostly fine, but sometimes quite speculative. Thus the scenario described for ROS-mediated aggregation of RCD1 and subsequent release of RCD1-dependent repression may still be considered as hypothesis. Were the ANAC13/ 17 targets expressed in the lines complemented with the heptuple Cys-to-Ser variant upon oxidative treatment?

Despite these points, I consider this submission as an important contribution to the field, which should attract attention of the wider readership.

Reviewer \#2:

In this study, Shapigzov, Vainonen et al. further explore the role of RCD1 (previously picked up in an ozone sensitivity screen) in regulation of electron transfer and retrograde signalling. The manuscript represents a vast amount of work and provides interesting findings in many aspects of stress response and signalling. The main novel point the study puts forward is that RCD1 may repress (mitochondrial) retrograde signalling via direct binding to ANAC013/17 transcription factors, and repressing their function. This system may be of importance during resistance to the ROS-generating herbicide methyl viologen (paraquat, leading to PSI superoxide and H~2~O~2~ production).

The study first confirms MV resistance of the *rcd1* mutant reported previously (e.g. Fujibe et al., 2004, Hiltscher et al., 2014). The authors show that *rcd1* mutants maintain Fv/Fm much better after light exposure in the presence of MV, compared to WT, but that this is not just because MV cannot reach PSI. This is accompanied by lower H~2~O~2~ production in *rcd1*, indicating that somehow loss of RCD1 (a nuclear protein) suppresses ROS formation by MV. The observation that 2-cys peroxiredoxin is in a more reduced state therefore makes sense as less H~2~O~2~ seems to be present in the *rcd1* cells.

The study then shifts focus to mitochondrial alternative respiration (AOX-dependent). AOX1a gene expression was previously found by this group to be induced in *rcd1* mutants, and this is further confirmed at the protein level and by increased KCN-resistant respiration. This indicates that the increased alternative respiration in *rcd1* is largely due to AOX1a activity. The authors further indicate an increased flux through e.g. glycolysis, indicating a different metabolic state, likely independent of AOX1a.

Pre-treatment with mitochondrial complex III inhibitor AA could partially mimic the *rcd1* resistance to MV in WT plants, indicating that mitochondrial retrograde signalling can be of importance in MV tolerance, which is very interesting. Inhibition of AOX by SHAM made the *rcd1* less MV tolerant, indicating the AOX is needed for full MV tolerance. This is one of the most interesting findings in the study, that AOX is part of the *rcd1* mechanism for MV resistance. Follow-up experiments however showed that overexpression of AOX1a itself was not sufficient to induce MV tolerance, and *rcd1* aox1a plants were as MV resistant as *rcd1*. This suggests that other isoforms than AOX1a may be important here, and that higher AOX capacity is not sufficient in itself, and there might be additional post-translational regulation. The point of the experiment shown in Figure 3A may not be very clear to the general reader, and needs better explanation.

The authors then check NADPH-MDH activity and malate content. Both are higher in *rcd1* than in Col-0 after MV treatment. Overall NADPH-MDH capacity was higher in *rcd1*, suggesting some flux of reductive equivalent to the mitochondria via chloroplastic malate formation. The increased activation state may again have to do with the lower ROS oxidation state of the *rcd1* cells.

A transcriptome meta-analysis further confirms the previous findings that many mitochondrial retrograde regulation target genes are constitutively induced in *rcd1*, as well as by MV.

The authors then make a link to another retrograde pathway mediated by PAP, which also co-regulates MDS gene expression (Van Aken and Pogson, 2017). The authors cross *rcd1* with a PAP accumulating mutant *sal1* and find a much stronger growth inhibition phenotype than either of the single mutants. Although this quite interesting in itself, the authors don\'t really provide a mechanistic explanation or suggestion for this additive phenotype. The Sal1 and *rcd1 sal1* mutants would need to be analysed in more detail (e.g. Fv/Fm MV analysis) to show PAP is really involved here.

Constitutive induction of MDS transcripts (including ANAC013) genes suggests that their main positive transcription factors are activated (ANAC017/013). To address this, the authors made the interesting cross of *rcd1* anac017. Indeed, AOX levels and capacity are lower in this double mutant, supporting the role of ANAC017 in MDS upregulation in *rcd1*. The anac017 mutant was previously shown to be highly MV-sensitive, and ANAC013/ANAC017 overexpression lines are more tolerant (e.g. De Clercq et al., 2013). The observed hypersensitivity of the anac017 mutant in the Fv/Fm MV assay is in line with this. The *rcd1* anac017 is more sensitive than *rcd1* indicating the NAC MRR pathway plays a partial role in the *rcd1* MV phenotype. No descriptions of the visual, developmental and stress (e.g. ozone) phenotype of the *rcd1 anac017* mutant are provided, which would be very interesting.

The authors then support the previously reported interaction of ANAC013 with RCD1 (Jaspers et al., 2009, O\'Shea et al., 2017) using Co-IP strategies, and provide further insight into the interaction with surface plasmon resonance and NMR.

Finally, the authors show that RCD1 protein level (or at least HA-RCD1) is degraded over time by MV and H~2~O~2~ treatment. Using non-reducing gels, they show that quickly after these treatments, a more oxidised multimeric form of RCD1 is found, indicating protein aggregation. From my interpretation of Figure 6B and Supp S5B, H~2~O~2~ makes a predominantly much higher MW aggregate than MV, so this should be discussed. By mutating 7 Cys residues in the RCD1 protein, the authors showed that this aggregation can be largely blocked. I am somewhat confused by the statement on mitochondrial inhibitor AA in the second paragraph of subsection "RCD1 protein is sensitive to organellar ROS" and Figure S5B. To me the total (reducing gel) abundance of RCD1 after AA is much lower than after MV. This seems in contrast to the statement in the text that RCD1 is not a direct target of a mitochondrial signal from AA. This should be clarified. Also H~2~O~2~ seems much stronger in affecting RCD1 abundance than MV. In line with this, MV is a much weaker inducer of MDS genes than AA or H~2~O~2~ (Figure 4A), so perhaps the role of RCD1 is of more importance in AA signalling than in MV, but this is under explored. In S5C, I assume the legend is mislabelled, where Col-0 should be the grey line? The identical phenotype of the 7cys RCD1 complementation compared to the normal RCD1 complementation, however questions the physiological importance of the RCD1 redox-induced aggregation, as one might expect then less efficient complementation.

Overall, the manuscript contains lots of data, and the experiments seem well performed so I trust their validity. To a large extent, many of the findings are confirming previous findings from the large body of literature surround RCD1 and MRR (binding with ANACs, upregulation of multiple MDS genes also in PAP-related mutants, MV tolerance phenotypes, potential involvement of AOX1a, involvement of ANAC013/17 in MV tolerance), and expand on them with additional techniques and measurements. The main model proposed here is that RCD1 binds and inhibits ANAC017/13, so mitochondrial retrograde signalling is blocked when no stress is present. Upon stress, the ROS-induced redox/changes alter RCD1 configuration/abundance and cause aggregation, which may reduce the inhibitory capacity of RCD1 on the NACs, thereby inducing MDS gene expression. This system is of importance also for chloroplast stress resistance such as MV, involving AOX activity.

If this is indeed true, that would be a major finding in the field, providing mechanistic insight into the relatively poorly understood ANAC MRR pathway. However, at this stage the evidence brought here is fairly circumstantial, with many nice experiments that however do not provide conclusive evidence. Many of the key findings that lead to this conclusion are already published (RCD1 ANAC interaction, induction of ANAC target genes in *rcd1* mutants, role of ANACs in MV resistance). Indeed, the interactions have now been confirmed by several labs independently and with great detail, so it seems very likely to occur. However, many mutants/treatments have activation of MDS genes as reported in many studies, but this may just indicate a basally stressed state of the plants (not-necessarily just ROS levels) leading to ANAC signalling, and not necessarily direct regulation on the transcription factor.

To make this more convincing, more direct experiments should be performed. One would for instance expect that an RCD1 Overexpression line (which has been made in the past, Fujibe 2006, Biosci. Biotechnol. Biochem., 70 (8), 1827-1831, and complements the *rcd1* MV resistance phenotype) would suppress (AA-induced) MRR to a significant extent. The 7cys RCD1 line would also be of interest in this context, to show that redox state can affect retrograde signalling. A complementation line of mutated RCD1 lacking the clearly defined ANAC interaction domain should not be able to restore wild-type levels of MV susceptibility and MDS upregulation, but I am not aware if one is available. Experiments showing a dynamic release of sequestration/binding of ANACs from RCD1 during stress would be even more convincing, but I agree these are technically very challenging.

Overall, the study provides many new insights and is well written, and soundly presented. To really make a convincing case for their exciting model, some more specific experiments targeting the ANAC/RCD1 regulation would be beneficial.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Arabidopsis RCD1 Coordinates Chloroplast and Mitochondrial Functions through Interaction with ANAC Transcription Factors\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Christian Hardtke (Senior Editor), a Reviewing Editor, and two reviewers.

The manuscript has been improved, but the reviewers are of the opinion that you did not adequately respond to key requests from the first round of reviews. We would thus like to ask you to carefully consider the reviews pasted below, and revise your manuscript accordingly.

*Reviewer \#1:*

In this revised version the authors addressed many small and large issues raised by the reviewers and editor. However, I feel some of the main concerns have not been addressed appropriately yet.

The authors try to introduce a new mechanism of how RCD1 directly binds and inhibits ANAC017/13. This possibly interaction represses the transcription factors and thus would keep MRR target gene expression under control, such as AOX1a. Upon oxidative stress, RCD1 aggregates and would then release some of the ANAC017/13 to induce MRR gene expression. This interesting model has a number of testable implications, which were suggested after initial review, and were also underlined to be important by the Editor. However some of these have not been addressed directly.

1\) In comment by *eLife* Senior Editor: \"One important experiment would be to look for suppression of NAC17-dependent retrograde signalling in an RCD overexpression and/or RCD 7cys complemented line. Notably, these lines should be readily available, and as such these are not very challenging experiments.\"

And reviewer 2 \"To make this more convincing, more direct experiments should be performed. One would for instance expect that an RCD1 Overexpression line (which has been made in the past, Fujibe 2006, Biosci. Biotechnol. Biochem., 70 (8), 1827-1831, and complements the *rcd1* MV resistance phenotype) would suppress (AA-induced) MRR to a significant extent. The 7cys RCD1 line would also be of interest in this context, to show that redox state can affect retrograde signalling.\"

The authors respond in point 1 that a number of *rcd1* RCD1-HA with higher and lower levels of RCD1 (thus probably equivalent to an RCD1 overexpression line, but hard to say without RCD1 specific antibody, and only an anti-HA antibody) have been generated. The authors then show the MV-dependent Fv/Fm phenotype is reverting to different extents to Col-0. This is nice, but the key experiment to address the raised question is then missing. When treated with a Mitochondrial Retrograde Regulation inducing agent (classically antimycin A), do these "overexpression" lines show a reduction in ANAC017-dependent MRR gene expression (e.g. Aox1a, UPOX, UGT74E2)? The authors did experiments along these lines but using MV (Figure 2---figure supplement 1D). MV however does not directly induce mitochondrial signalling as it mainly affects chloroplastic ROS, which is supported by the fact that MRR marker genes AOX1a and UPOX are not induced by MV (Figure 2---figure supplement 1D). I don\'t see why the authors did not do the same experiment using AA, which would address the question, and is relatively easy to perform. In the RCD1d7cys complemented line, which fails to aggregate, such a repression of AA-induction of MRR genes may not occur, and would thus be expected to show more WT-like gene expression responses.

2\) A second experiment that was suggested was to use *rcd1* mutants complemented with RCD1 lacking the ANAC017 interaction domain (RST domain). In point 3 the authors describe RCD1dRST-HA complementation lines were generated. I assume this is indeed transformation into the *rcd1* mutant background, so I suggest these line are called *rcd1* RC1dRST-HA in the text and figures (e.g. Figure 7B-C), same for *rcd1* RCD1-HA. This to avoid confusion that they are in the Col-0 background, which would lead to a different interpretation. The results in Figure 7B and C are indeed in line with the fact that the RST1 domain is important for RCD1 function in this context. As RCD1 is known to interact with a wide range of transcription factors, so it is not direct evidence for a role via interaction with ANAC017/13, but overall that is a nice result.

3\) My comments regarding the size of the aggregates have been addressed.

4\) Also the comments regarding Fv/Fm measurement on the *rcd1 sal1* have been addressed, it is interesting to see that it shows much higher tolerance to MV than *rcd1* itself.

5\) I still think it is important to show the visual phenotype of the *rcd1 anac017* mutant plants, even if they don\'t seem to revert the *rcd1* ozone resistance phenotype, as is partially observed for the MV Fv/Fm phenotype. This makes some sense, as *anac017* is not known to be involved in ozone tolerance.

6\) I don\'t really understand the author\'s reasoning in point 37 of their reply letter. The authors say there is no effect of AA on RCD1-HA redox state, but Figure 4---figure supplement 2B to me shows induction of higher order complexes by AA and myx of the same size as MV in light or H~2~O~2~, albeit weaker. 2.5 μm is a relatively low concentration, as 50 μm AA has been used most extensively throughout the literature. They also say that because MDS gene induction (by which they mean AOX protein level changes using Western blots) by AA is still occurring in *rcd1*, this leads them to conclude that RCD1 is unlikely part of AA signalling. As RCD1 is suggested to suppress ANAC017 signalling, an *rcd1* KO should still show AA gene induction, as the potential repressor is now inactive. An RCD1 OX line may display reduction in AA signalling, but this question has still not been addressed, see Point 1.

Reviewer \#2:

The authors have thoroughly revised their previous manuscript version and provide additional evidence for their lines of thoughts and conclusions. The study contributes important and novel information to our understanding of retrograde signaling and the integration of chloroplast and mitochondrial retrograde signals. In the following you find the combined list of minor and very few more critical points.

Introduction section, first paragraph: "... transport of carbon rich metabolites..." It is not really clear what is meant? Carbon rich might be a fatty acid? energy-rich like dihydroxyacetone phosphate or malate?

Introduction section, second paragraph: "... leakage of electrons..."; is this still an adequate description of the process? Our concept of ROS signaling more and more assumes that ROS are generated to enable regulation.

Introduction section, fourth paragraph: "... provides positive feedback regulation"; please be more precise and give the direction:.... provides positive feedback and thus enhancement of the signal.

Subsection "Mitochondrial respiration is altered in *rcd1*", opening sentence: I would omit the U here, since it is confusing for the non-expert, and in the legend and Materials and methods it will be mentioned. But in fact the uniformity of label is not explained, is it?

Subsection "Retrograde signaling from both chloroplasts and mitochondria is altered in *rcd1*": msh1, recA3 (add comma)

Discussion third: In the same paragraph: "suggests that RCD1 is not a redox sensor of mitochondrial ROS/ redox signaling" still sounds like an overinterpretation of the data and should be toned down. "unlikely is...." In fact in context with the subsequent discussion, it is not really clear what this statement means. If mitochondrial alterations in metabolism cause redox changes in the nucleus/cytosol similar to those of the chloroplast, then the conformational changes should be the same. The power of mitochondrial redox/ROS signals may just be less than chloroplast redox/ROS signals.

Subsection "RCD1 regulates stress responses and cell fate", first paragraph: Rap2.4a

10.7554/eLife.43284.080

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> 1\) One important experiment would be to look for suppression of NAC17-dependent retrograde signalling in an RCD overexpression and/or RCD 7cys complemented line. Notably, these lines should be readily available, and as such these are not very challenging experiments.

1\) To show dependence on *rcd1* phenotypes on abundance of expressed RCD1, we included new results on MV tolerance in the *rcd1* complementation lines expressing different levels of RCD1-HA (Figure 1---figure supplement 1). These lines were used instead of the RCD1-overexpressor line reported in (Fujibe, T. et al., 2006), because the latter line has raised concerns about possible induced silencing of *RCD1* or other members of the *SRO* gene family.

2\) The lines expressing RCD1Δ7Cys-HA have now been described in more detail. New data has been added on MV tolerance and expression of MDS genes in these lines (Figure 2---figure supplement 1C, D). in vivoabundance of RCD1Δ7Cys-HA in comparison to RCD1-HA has been addressed (Figure 2---figure supplement 1C).

3\) New data on RCD1ΔRST-HA complementation lines was generated and added. These lines express an RCD1 variant lacking the NAC interaction domain. AOX abundance and MV tolerance have been assessed in these lines (Figure 7B, C).

> 2\) It must be clarified whether the initial MDH activity was indeed measured after 2 h of incubation in the absence of DTT, as it presently reads in subsection "Measurements of NADPH-MDH activity". This would have caused inactivation. If the non-aqueous fractions still exist, chloroplast malate levels would be most interesting rather than whole leaf amounts.

4\) The required information has been added to the Figure 5C legend and to Materials and methods. The initial NADPH-MDH activity was measured directly following the extraction. The 2-hour incubation was only performed in presence of 150 mM DTT prior to the measurement of the total NADPH-MDH activity.

5\) The distribution of malate was measured in non-aqueous fractions isolated from Col-0 and *rcd1*. The data was included as Figure 5---figure supplement 2.

> 3\) Finally, the manuscript should be substantially rewritten and rearranged. In particular, you would have to streamline your paper and focus on the novel aspects. Confirmatory experiments with respect to the literature should receive less attention and be displayed in the extended data. Moreover, often the results can only be understood when investigating the figure, reading the legend, the corresponding section in the Materials and methods and the text passage. You should aim to ease this process. For example you could provide the most important information in the legend, e.g. the light intensity used for NADPH-MDH-activity measurement (Figure 3), the incubation time with MV in Figure 3B or the positions of standard polypeptides in the Western blots.

6\) The manuscript has been profoundly revised. In particular, the Results, the figure legends and the supplements have been entirely rearranged and rewritten to facilitate the reading.

7\) The description of the experiments that were not directly related to the central message of the manuscript, or the confirmatory experiments, was shifted to the supplemental figure legends.

8\) Comprehensibility of the figures was increased by including necessary explanations and experimental details in the figures and figure legends. Positions of molecular weight markers were added to immunoblot images where necessary. All figures were graphically redesigned to facilitate visual display of the data.

> Reviewer \#1:
>
> The strength of the study is that the authors attempt to test their hypotheses by using specific mutants. Another important point is the establishment of the link between the RCD1-dependent signaling and ANAC13/ 17, physically (shown before) and now deepened for the proteins ANAC13/ ANAC17/ SRO1/ RCD1 (also in human embryonic kidney cell; these results could move to the supplementary materials), indirectly functionally by corresponding changes in the transcriptomes and by increased ROS sensitivity of rd1/anac17 double mutants. The structural part on the interaction between RCD1 and ANAC13/ 17 is also significant.

*It has to be taken with caution that H~2~O~2~and methylviologen treatments specifically mimic chloroplast ROS production. This must be discussed with more care, also in the Discussion final paragraph. Exogenous application of H~2~O~2~acts in different cells and cell compartments, likewise MV supplementation is not a specific inducer of chloroplast ROS. Thus high light treatment affects analyzed parameters different to H~2~O~2~ and methylviologen.*

This concern has been addressed by adding a data panel showing that MV only triggered RCD1 oligomerization under light, but not in the darkness (Figure 4---figure supplement 2B). This observation hints on chloroplastic origin of ROS. In addition, oligomerization of RCD1 was addressed in presence of the mitochondrial ETC inhibitors (AA and myx; Figure 4---figure supplement 2B). The latter treatments did not affect the status of RCD1.

> Figure 3: Subsection "Evidence for increased electron transfer between chloroplasts and mitochondria in rcd1": The activation state of NADPH malate dehydrogenase (MDH) is very low, almost unbelievably low (4-8%). Doubling the activity from this very low activation state unlikely is sufficient to explain any changes in rcd1 mutants. Kinetic modelling could help to define whether the observation is significant or not. The legend to the figure is insufficient to understand what is measured. Describe the photosynthetic condition the leaves were exposed to here. The concern with this interpretation is strengthened by the unchanged NADPH/NADP-ratio in non-aqueously isolated chloroplasts. The incubation of the test with and without DTT for 2 h at room temperature is not clear: Was the minus DTT-sample supposed to be the initial activity? During a 2 h incubation with 250 μM DTT, the initially active MDH may inactivate and this may explain the extremely low activity? This ambiguity must be clarified. Possibly the measurements would have to be repeated if they are considered to be central to the paper.

The required information has been added to the Figure 5C legend and to Materials and methods. The activation state of NADPH-MDH is dependent on the growth conditions and light intensity. Low values obtained in this study may be associated with growth conditions (100-120 μmol m-2 s^-1^ at an 8-hour day photoperiod). Most importantly, the NADPH-MDH activation state was different between *rcd1* and Col-0, while the absolute values of this parameter are of secondary importance for the study. However, these values are comparable to those previously reported in tomato (Centeno, D. C. et al., 2011, The Plant Cell).

> The comfort of reading is not always optimal at present since the reader must simultaneously consult the text, the legend and the method.

As has been outlined in \#\#6-8, the manuscript including the figure legends has been profoundly rewritten to facilitate the reading.

> The high concentrations of NADH and NADPH in the vacuole appears surprising and an artefact. The description of the method and results may not be complete here. Which other compartment markers were measured and included in the best fit? May be it would be more reliable and convincing to present total leaf nucleotide levels rather than somewhat questionable date on subcellular compartments. The statistically significant difference in vacuolar NADH points to severe problems with this method.

Non-aqueous fractionation does not allow separation of vacuolar and apoplastic compartments, which is likely to be the source of the discrepancy. To clarify this, the figures (Figure 1---figure supplement 4C and Figure 5---figure supplement 2) have been corrected, "vacuole" compartment has been relabelled as "vacuole/ apoplast". Figure 1---figure supplement 4C legend was updated by adding the following text: "Note that the method does not allow for separation of apoplastic and vacuolar compartments or reliable definition of the mitochondria (Fettke et al., 2005)".

> The discussion is mostly fine, but sometimes quite speculative. Thus the scenario described for ROS-mediated aggregation of RCD1 and subsequent release of RCD1-dependent repression may still be considered as hypothesis. Were the ANAC13/ 17 targets expressed in the lines complemented with the heptuple Cys-to-Ser variant upon oxidative treatment?

The Discussion and the Figure 8 legend have been modified to highlight the hypothetical nature of the proposed regulation. The expression of the ANAC013 /ANAC017-regulaterd genes in the RCD1Δ7Cys-HA line has been assessed (see answer \#2). This new data was added as Figure 2---figure supplement 1D.

> Reviewer \#2:
>
> In this study, Shapigzov, Vainonen et al. further explore the role of RCD1 (previously picked up in an ozone sensitivity screen) in regulation of electron transfer and retrograde signalling. \[...\] The point of the experiment shown in Figure 3A may not be very clear to the general reader, and needs better explanation.

The measurement of Fs under combined treatment with MV and SHAM has been described in more detail in the Results and in the Figure 5A legend. In addition, new Figure 1---figure supplement 1A has been introduced to familiarize the reader with the chlorophyll fluorescence parameters addressed in the study. Furthermore, as a parallel approach to the Fs measurement, PSII photochemical quenching was measured as presented in Figure 5---figure supplement 1.

> The authors then check NADPH-MDH activity and malate content. Both are higher in rcd1 than in Col-0 after MV treatment. Overall NADPH-MDH capacity was higher in rcd1, suggesting some flux of reductive equivalent to the mitochondria via chloroplastic malate formation.\[...\] The Sal1 and rcd1 sal1 mutants would need to be analysed in more detail (e.g. Fv/Fm MV analysis) to show PAP is really involved here.

MV tolerance of *sal1* and *rcd1 sal1* mutants has been assessed and presented as Figure 6---figure supplement 2.

> Constitutive induction of MDS transcripts (including ANAC013) genes suggests that their main positive transcription factors are activated (ANAC017/013). To address this, the authors made the interesting cross of rcd1 anac017. Indeed, AOX levels and capacity are lower in this double mutant, supporting the role of ANAC017 in MDS upregulation in rcd1. The anac017 mutant was previously shown to be highly MV-sensitive, and ANAC013/ANAC017 overexpression lines are more tolerant (e.g. De Clercq et al., 2013). The observed hypersensitivity of the anac017 mutant in the Fv/Fm MV assay is in line with this. The rcd1 anac017 is more sensitive than rcd1 indicating the NAC MRR pathway plays a partial role in the rcd1 MV phenotype. No description of the visual, developmental and stress (e.g. ozone) phenotype of the rcd1 anac017 mutant is provided, which would be very interesting.

In the *rcd1 anac017* double mutant the curly leaf and the ozone sensitivity phenotypes were not complemented. We believe that demonstrating this data would distract the reader from the storyline and complicate the reading. Our results suggest that this phenotype is largely independent from the organelle interactions (this is addressed in the last paragraph of Discussion and mentioned in Figure 6---figure supplement 1 legend).

> The authors then support the previously reported interaction of ANAC013 with RCD1 (Jaspers et al., 2009, O\'Shea et al., 2017) using Co-IP strategies, and provide further insight into the interaction with surface plasmon resonance and NMR.

*Finally, the authors show that RCD1 protein level (or at least HA-RCD1) is degraded over time by MV and* H~2~O~2~*treatment. Using non-reducing gels, they show that quickly after these treatments, a more oxidised multimeric form of RCD1 is found, indicating protein aggregation. From my interpretation of Figure 6B and Supp S5B,* H~2~O~2~*makes a predominantly much higher MW aggregate than MV, so this should be discussed.*

The apparent different positions of H~2~O~2~ and MV-related aggregates of RCD1 in the old version of Figure S5B was an artefact caused by the bending of the stacking gel. To avoid discrepancies, this figure has been replaced with the new Figure 4---figure supplement 2B. As it is clear from the new figure, in both treatments the aggregates migrate at a similar height.

*By mutating 7 Cys residues in the RCD1 protein, the authors showed that this aggregation can be largely blocked. I am somewhat confused by the statement on mitochondrial inhibitor AA in the second paragraph of subsection "RCD1 protein is sensitive to organellar ROS" and Figure S5B. To me the total (reducing gel) abundance of RCD1 after AA is much lower than after MV. This seems in contrast to the statement in the text that RCD1 is not a direct target of a mitochondrial signal from AA. This should be clarified. Also* H~2~O~2~*seems much stronger in affecting RCD1 abundance than MV. In line with this, MV is a much weaker inducer of MDS genes than AA or* H~2~O~2~*(Figure 4A), so perhaps the role of RCD1 is of more importance in AA signalling than in MV, but this is under explored.*

In the old Figure S5B antimycin A (AA) was used in the concentration 20 μM, which is much higher than in rest of this study (2.5 uM). The decrease in RCD1-HA abundance was reproducibly observed under 20 μM AA, but not under 2.5 μM AA. However, the data on 20 μM AA is hard to interpret due to possible chloroplastic off-target effects of ≥ 20 μM AA, as described in (Watanabe et al., 2016). Most importantly for this study, 2.5 μm AA (or 2.5 μm myxothiazol) was sufficient for MDS gene induction, however it did not lead to changes in either RCD1-HA abundance or redox states. To show this, the new figures were added to the manuscript (Figure 4---figure supplement 2A, B). The ambiguous results with 20 μM AA were excluded. Together with the fact that AA- or myx-triggered MDS gene induction was also observed in the *rcd1* mutant (Figure 4---figure supplement 1B) this suggested that RCD1 is unlikely part of the AA signalling. The Discussion has been updated to state this more explicitly.

> In S5C, I assume the legend is mislabelled, where Col-0 should be the grey line? The identical phenotype of the 7cys RCD1 complementation compared to the normal RCD1 complementation, however questions the physiological importance of the RCD1 redox-induced aggregation, as one might expect then less efficient complementation.

For the clearer demonstration of MV tolerance of RCD1-HA and RCD1Δ7Cys-HA complementation lines, the new datasets have been added to the manuscript (Figure 1---figure supplement 1B, and Figure 2---figure supplement 1C). As can be seen in these figures, at certain low MV concentration some of the RCD1-HA complementation lines are more sensitive to MV than Col-0 (which was visible in the old Figure S5C). The added data shows that mutation of the RCD1 cysteines affects in vivoabundance and stability of the protein. This has been addressed in Results and in Discussion.

> Overall, the manuscript contains lots of data, and the experiments seem well performed so I trust their validity. \[...\]
>
> To make this more convincing, more direct experiments should be performed. One would for instance expect that an RCD1 Overexpression line (which has been made in the past, Fujibe 2006, Biosci. Biotechnol. Biochem., 70 (8), 1827-1831, and complements the rcd1 MV resistance phenotype) would suppress (AA-induced) MRR to a significant extent. The 7cys RCD1 line would also be of interest in this context, to show that redox state can affect retrograde signalling.

These questions have been addressed. Please, refer to the answers \#\#1, 2.

> A complementation line of mutated RCD1 lacking the clearly defined ANAC interaction domain should not be able to restore wild-type levels of MV susceptibility and MDS upregulation, but I am not aware if one is available. Experiments showing a dynamic release of sequestration/binding of ANACs from RCD1 during stress would be even more convincing, but I agree these are technically very challenging.

This question has been addressed. Please, refer to the answer \#3.

> Overall, the study provides many new insights and is well written, and soundly presented. To really make a convincing case for their exciting model, some more specific experiments targeting the ANAC/RCD1 regulation would be beneficial.

\[Editors\' note: the author responses to the re-review follow.\]

> Reviewer \#1:
>
> In this revised version the authors addressed many small and large issues raised by the reviewers and editor. However, I feel some of the main concerns have not been addressed appropriately yet.
>
> The authors try to introduce a new mechanism of how RCD1 directly binds and inhibits ANAC017/13\[...\] This interesting model has a number of testable implications, which were suggested after initial review, and were also underlined to be important by the Editor. However some of these have not been addressed directly.
>
> 1\) In comment by eLife Senior Editor: \"One important experiment would be to look for suppression of NAC17-dependent retrograde signalling in an RCD overexpression and/or RCD 7cys complemented line\[...\] The 7cys RCD1 line would also be of interest in this context, to show that redox state can affect retrograde signalling.\"
>
> The authors respond in point 1 that a number of rcd1 RCD1-HA with higher and lower levels of RCD1 (thus probably equivalent to an RCD1 overexpression line, but hard to say without RCD1 specific antibody, and only an anti-HA antibody) have been generated.

In response to these concerns raised by the reviewers, additional data has been added to the study, as follows:

1\) Abundance of RCD1 protein in different *rcd1*: RCD1-HA complementation lines in comparison to the wild type has been assessed in Figure 1---figure supplement 1B. Information on the antibody against RCD1 that we have generated has been added to the Materials and methods section.

2\) Abundance of *RCD1* mRNA in the *rcd1*: RCD1-HA lines was measured by qPCR and compared to that in the wild type. This has been included as Figure 1---figure supplement 1C. Taken together, the immunoblotting and the qPCR results demonstrate that the *rcd1*: RCD1-HA lines expressing higher levels of RCD1-HA are the true overexpressors of RCD1, as the level of both the RCD1 protein and the *RCD1* transcript exceed those in Col-0 about 10-fold. Moreover, in the *rcd1*: RCD1-Venus lines that we generated, *RCD1* is expressed under *UBIQUITIN-10* promoter. In these lines RCD1 accumulates to amounts even higher than in the shown high-expressor *rcd1*: RCD1-HA lines. However, even in the *pUB10:RCD1* lines we have never observed any signs of restoration of the *rcd1*-like phenotypes. Thus, we believe that the physiological response reported in (Fujibe et al., 2006) is not associated with overexpression of RCD1 protein, but has to do with more complex secondary effects such as silencing of other members of the SRO family. Thus, for the experiments proposed by the reviewers we have used the set of independent *rcd1*: RCD1-HA lines expressing different levels of RCD1-HA (please, see below).

> The authors then show the MV-dependent Fv/Fm phenotype is reverting to different extents to Col-0. This is nice, but the key experiment to address the raised question is then missing. When treated with a Mitochondrial Retrograde Regulation inducing agent (classically antimycin A), do these "overexpression" lines show a reduction in ANAC017-dependent MRR gene expression (e.g. Aox1a, UPOX, UGT74E2)? The authors did experiments along these lines but using MV (Figure 2 sup 1D). MV however does not directly induce mitochondrial signalling as it mainly affects chloroplastic ROS, which is supported by the fact that MRR marker genes AOX1a and UPOX are not induced by MV (Figure 2---figure supplement 1D). I don\'t see why the authors did not do the same experiment using AA, which would address the question, and is relatively easy to perform. In the RCD1d7cys complemented line, which fails to aggregate, such a repression of AA-induction of MRR genes may not occur, and would thus be expected to show more WT-like gene expression responses.

The suggested experiment has been conducted. The new data has been added as Figure 6---figure supplement 2 (induction of MDS genes after 3-hour treatment with 50 μm AA in Col-0, *rcd1*, independent *rcd1*: RCD1-HA and independent *rcd1*: RCD1Δ7Cys-HA lines), and as Figure 8---figure supplement 1 (same treatment performed in the *rcd1-1 anac017* double mutant). As outlined above, *rcd1*: RCD1-HA lines expressing higher levels of RCD1-HA were used as RCD1 overexpressors. In agreement with the reviewer's prediction, we have observed suppressed induction of the *UPOX* gene in the *rcd1*: RCD1-HA high expressor line and in the *rcd1*: RCD1Δ7Cys-HA lines.

> 2\) A second experiment that was suggested was to use rcd1 mutants complemented with RCD1 lacking the ANAC017 interaction domain (RST domain). In point 3 the authors describe RCD1dRST-HA complementation lines were generated. I assume this is indeed transformation into the rcd1 mutant background, so I suggest these line are called rcd1 RC1dRST-HA in the text and figures (e.g. Figure 7B-C), same for rcd1 RCD1-HA. This to avoid confusion that they are in the Col-0 background, which would lead to a different interpretation.

The figures and the text have been modified accordingly.

> The results in Figure 7B and C are indeed in line with the fact that the RST1 domain is important for RCD1 function in this context. As RCD1 is known to interact with a wide range of transcription factors, so it is not direct evidence for a role via interaction with ANAC017/13, but overall that is a nice result.
>
> \[...\] 5) I still think it is important to show the visual phenotype of the rcd1 anac017 mutant plants, even if they don\'t seem to revert the rcd1 ozone resistance phenotype, as is partially observed for the MV Fv/Fm phenotype. This makes some sense, as anac017 is not known to be involved in ozone tolerance.

Since previous version of the manuscript, we have discovered growth conditions under which we see partial complementation of *rcd1* habitus phenotype in the *rcd1 anac017* double mutant. This was included as the new main figure data panel. To make the results presented in the crowded former Figure 7 more visual, this figure was split in two: Figure 7 and Figure 8.

*6) I don\'t really understand the author\'s reasoning in point 37 of their reply letter. The authors say there is no effect of AA on RCD1-HA redox state, but Figure 4---figure supplement 2B to me shows induction of higher order complexes by AA and myx of the same size as MV in light or* H~2~O~2~*, albeit weaker. 2.5 μm is a relatively low concentration, as 50 μm AA has been used most extensively throughout the literature. They also say that because MDS gene induction (by which they mean AOX protein level changes using Western blots) by AA is still occurring in rcd1, this leads them to conclude that RCD1 is unlikely part of AA signalling. As RCD1 is suggested to suppress ANAC017 signalling, an rcd1 KO should still show AA gene induction, as the potential repressor is now inactive. An RCD1 OX line may display reduction in AA signalling, but this question has still not been addressed, see Point 1.*

As stated above, transcriptional response to higher concentration of AA (50 uM) has been addressed and included in the manuscript. In our opinion, the experiment proposed by the reviewers has significantly added to this manuscript. In particular, it showed that *rcd1* mutant was not affected in the initiation of MDS signalling, that the overexpressor and the RCD1Δ7Cys lines had this signalling somewhat suppressed, and that ANAC017 played decisive role in the initiation of the MDS signal both in Col-0 and in *rcd1*.

At the same time, we believe that the in vivo studies of RCD1 under 50 μm AA should be interpreted with caution, because (i) RCD1 may be sensitive to redox states of various subcellular origin, and (ii) high concentrations of AA are known to inhibit chloroplast cyclic electron flow (on which account a cautionary note has been included in the legend of Figure 6---figure supplement 2). This makes it harder to interpret the effects of high concentrations of AA on RCD1 biochemistry and redox states. Nevertheless, we agree with the reviewers that the possibility of RCD1 acting as a redox sensor of the mitochondrial MDS signalling has not been ruled out in this study. To account for this uncertainty, the Discussion text has been modified accordingly. ("In addition, little change was observed (in RCD1 abundance and redox state) with the mitochondrial complex III inhibitors AA or myx (Figure 4---figure supplement 2A, B). Together with the fact that MDS induction was not compromised in the *rcd1* mutant (Figure 4---figure supplement 1 and Figure 6---figure supplement 2), this suggests that RCD1 may primarily function as a redox sensor of chloroplastic, rather than mitochondrial, ROS/ redox signaling.")

> Reviewer \#2:
>
> \[...\] In the following you find the combined list of minor and very few more critical points.
>
> Introduction section, first paragraph: "... transport of carbon rich metabolites..." It is not really clear what is meant? Carbon rich might be a fatty acid? energy-rich like dihydroxyacetone phosphate or malate?

The text has been clarified by changing it to "...transport of photoassimilate-derived carbon rich metabolites from chloroplasts to mitochondria." We believe that such wording would be the most accurate in describing compounds, which may undergo conversion after their export from the plastid and before import into the mitochondria.

> Introduction section, second paragraph: "... leakage of electrons..."; is this still an adequate description of the process? Our concept of ROS signaling more and more assumes that ROS are generated to enable regulation.

The wording "occasional leakage" has been replaced with "transfer".

> Introduction section, fourth paragraph: "... provides positive feedback regulation"; please be more precise and give the direction:.... provides positive feedback and thus enhancement of the signal.

The text has been modified accordingly.

> Subsection "Mitochondrial respiration is altered in rcd1", opening sentence: I would omit the U here, since it is confusing for the non-expert, and in the legend and Materials and methods it will be mentioned. But in fact the uniformity of label is not explained, is it?

We assume that the fact that glucose was uniformly labelled is essential for correct interpretation of the results. Thus, it was kept in the text. Definition of the abbreviation has been added in the first use, to facilitate readability.

> Subsection "Retrograde signaling from both chloroplasts and mitochondria is altered in rcd1": msh1, recA3 (add comma)

*msh1 recA3* is a double mutant and according to Arabidopsis gene nomenclature standard it should be presented as it was in previous submission.

> Discussion third paragraph: "suggests that RCD1 is not a redox sensor of mitochondrial ROS/ redox signaling" still sounds like an overinterpretation of the data and should be toned down. "unlikely is..." In fact in context with the subsequent discussion, it is not really clear what this statement means. If mitochondrial alterations in metabolism cause redox changes in the nucleus/cytosol similar to those of the chloroplast, then the conformational changes should be the same. The power of mitochondrial redox/ROS signals may just be less than chloroplast redox/ROS signals.

The text in the Discussion has been modified accordingly. Please, see the reply above.

> Subsection "RCD1 regulates stress responses and cell fate", first paragraph: Rap2.4a

The phrase in question referred to the families of the transcription factors, not to their individual members.
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